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DNA stores the information that cells need to function, grow, and divide. However, DNA 
is constantly being damaged. Therefore, cells need to efficiently recognize and repair damage in 
their DNA to survive. Chromosome double strand breaks are a particularly toxic form of DNA 
damage that cells repair in one of three ways: non-homologous end joining, homologous 
recombination, and polymerase theta-mediated end joining. This dissertation is dedicated to 
improving our understanding of polymerase theta-mediated end joining, an error-prone 
chromosome break repair pathway that is rarely used in normal cells, but that many cancer cells 
rely on for survival.  
Mechanistically, polymerase theta-mediated end joining takes advantage of 
microhomologies, small patches of identical sequences present at both side of a chromosome 
break. First, I show how polymerase theta finds these microhomologies, in a way that minimizes 
the amount of lost DNA, and also how, when microhomologies are not present, polymerase 
theta is able to create them.  
Then, I systematically test which substrates polymerase theta is able to use in the repair 
of chromosome breaks, which helps characterize the beginning of the pathway. The versatility I 
observe makes polymerase theta-mediated end joining an ideal pathway for the repair of breaks 
with end structures that are not amenable to non-homologous end joining and homologous 
iv 
recombination. I also describe the last two steps of the pathway, which involve nucleolysis and 
DNA synthesis. 
Finally, I characterize the genetic interaction between polymerase theta and the Holliday 
junction resolvases, proteins involved in a potentially mutagenic form of homologous 
recombination, and determine that polymerase theta protects against this detrimental form of 
repair.  
Throughout the dissertation, I describe multiple circumstances in which, even though the 
use of polymerase theta-mediated end joining guarantees a small loss of DNA, it also protects 
against more pathogenic forms of repair. This helps explain the paradoxical observation that this 
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CHAPTER 1: INTRODUCTION 
 
“La ciencia es sin disputa el mejor, el más brillante adorno del hombre.” 
(Science is without dispute the best, the brightest ornament of man.) 
−Gaspar Melchor de Jovellanos 
DNA double strand breaks 
DNA stores the information that all organisms need to survive, and its chemical 
characteristics exquisitely serve this purpose. For instance, the specific pairing between the 
nitrogen bases allows DNA to be copied, and therefore transmitted from a cell to its daughter. 
Another beneficial characteristic of DNA is its chemical stability, especially when compared to 
other biomolecules such as RNA or proteins. This allows for the information to be propagated 
almost unchanged from one organism to its descendants, a key characteristic of life as we 
understand it. 
However, chemical reactions that alter DNA do happen, and this is known as DNA 
damage. The DNA of all organisms is frequently damaged, and this damage can take many 
forms. Modifications or loss of nitrogen bases, breakage of the phosphodiester bonds, or the 
formation of covalent bonds with other biomolecules, are common forms of DNA damage, and 
they threaten the genomic stability of cells. Consequently, all organisms need a DNA damage 
repair machinery that recognizes and repairs DNA, most of the times leaving it as if no damage 
had occurred. Occasionally, there is a change in the DNA sequence after the damage is 
repaired, and these changes are referred to as mutations. 
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One challenging form of DNA damage are chromosome double strand breaks (DSBs), 
which happen when both strands of the DNA are broken (Fig 1.1). The lack of an intact 
complementary strand within the same DNA molecule, where the genetic information still 
remains unchanged, makes this type of break particularly mutagenic. Chromosome breaks 
occur during normal biological processes (e.g., replication, transcription) or due to the exposure 
of DNA to cellular metabolites or exogenous molecules (mutagens) (Chapman et al. 2012; 
Scully et al. 2019). In addition, specialized biological processes create DSBs in their own DNA 
that need to be repaired. This allows for the generation of diversity in an organism’s progeny, 
through meiotic recombination, or in its adaptive immune response, through V(D)J and class 
switch recombination, key processes in the development of antibodies (Chapman et al. 2012; 
Scully et al. 2019). For this reason, it is not surprising that diseases caused by deficiencies in 
genes involved in DSB repair are often characterized severe immunodeficiencies (Zhao et al. 
2020). 
In addition, DSB repair is very important for cancer. Mutations in certain genes involved 
in DSB repair (e.g., BRCA1 and BRCA2) lead to a large increase in susceptibility to tumor 
development, likely due to an increased usage of error-prone DSB repair pathways (Prakash et 
al. 2015). Alternatively, commonly used cancer treatments – for instance radiotherapy, or the 
chemotherapeutic drug etoposide – work by generating DSBs in cancer cells as a way of killing 
them. For these reasons, mechanistic and genetic understanding of DSB repair can help 
understand tumor formation, as well as contribute in the development of new antitumor drugs 
(Aparicio et al. 2014; Trenner and Sartori 2019). 
Finally, because they are highly mutagenic, DSBs are ideal intermediates in gene 
editing. Targeted nucleases – the most important of which is Cas9 – can be used to make a 
DSB in a specific site in the genome. Mutagenic end joining, or repair using an exogenous 
template, can be used to inactivate, change the function, or correct mutations in genes, making 
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understanding DSB repair key for gene therapy and genome engineering (Jasin and Haber 
2016; Yeh et al. 2019). 
Chromosome break repair 
In eukaryotic cells, two pathways repair most chromosome breaks: Non-homologous 
end joining (NHEJ), which joins the ends back together, and homologous recombination (HR), 
which uses another DNA molecule as template for repair. NHEJ is available throughout the cell 
cycle, and is most common in G1 and G2, while HR is usually restricted to S-phase and G2, 
when a DNA molecule identical to the broken one, a sister chromatid, is available. Lower 
eukaryotes rely mostly on HR, while NHEJ dominates in most mammalian cells, especially post-
mitotic ones (Chapman et al. 2012; Zhao et al. 2020). Specialized forms of HR and NHEJ repair 
DSBs generated during meiosis and antibody development respectively. The descriptions 
provided below of how NHEJ and HR operate correspond to the repair of breaks generated 
spontaneously, and don’t include these specialized versions.  
During NHEJ, the DNA-PK complex, formed by the Ku heterodimer (Ku70 and Ku80) 
and DNA-PKcs first recognizes the ends of the chromosome break (Fig 1.1). Because the ends 
of a DSB commonly have other lesions associated, such as lost or modified bases, some 
processing might be necessary before ends can be ligated. NHEJ end-processing enzymes 
include DNA polymerases lambda and mu, which synthesize small amounts of DNA to make the 
ends complementary, nucleases (e.g., artemis or SNM1A), that can trim ligase-inhibitory 
lesions, or enzymes, such as TDP2, that free DNA from covalently bound proteins (Fig 1.1). 
Finally, the ends are ligated by DNA ligase 4 (LIG4), a ligase specifically designed to join 
complex double stranded DNA ends (Fig 1.1) (Waters et al. 2014b; Zhao et al. 2020). 
NHEJ has traditionally been described as an error-prone pathway, and it is common to 
see NHEJ make small (≤5 bp) deletions and insertions (Waters et al. 2014b). This is likely due 
to the difficulty in experimentally distinguishing non-broken DNA from non-mutagenic repair. 
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However, the use of exogenous DNA substrates, as well as of clever chromosome break repair 
assays that involve two DSBs, have challenged this notion (Waters et al. 2014a; Bhargava et al. 
2018). The importance of NHEJ for normal cell function is evidenced by the fact that loss of 
LIG4, as well as its key helper protein XRCC4, is lethal in mice, and Ku mutant mice, while 
viable, have severely reduced lifespans and sizes (Nussenzweig et al. 1996; Barnes et al. 1998; 
Frank et al. 1998; Gao et al. 1998; Vogel et al. 1999). 
HR is a more complex pathway. The first step in HR is 5’-to-3’ end resection of DNA 
ends, which generates two long 3’ ssDNA tails (Fig 1.1). End resection is considered the 
decision point between NHEJ and HR, as Ku has low affinity for ssDNA (Chapman et al. 2012). 
It is a tightly regulated process, with multiple pro-resection (MRN complex, BRCA1) and anti-
resection (53BP1, Shieldin) factors (Scully et al. 2019). After resection, the recombinase 
RAD51, aided by several other proteins (BRCA2 and, RAD51 paralogs) uses one of the ssDNA 
tails to invade another duplex DNA molecule, forming a displacement loop (D-loop), which 
primes DNA synthesis. Unwinding of the D-loop by the BLM helicase and reannealing to the 
other end of the broken molecule completes synthesis-dependent strand annealing (SDSA) (Fig 
1.1). Alternatively, the D-loop may progress to form a joint molecule, termed double Holliday 
junction, that needs to be dissolved (by BLM and Topoisomerase 3 alpha) or resolved (by the 
SMX meganuclease or GEN1) for the chromosomes to be segregated; the latter process can 
lead to a mitotic crossover (Chapman et al. 2012; Scully et al. 2019). 
HR is generally considered error free, due to its ability to use a sister chromatid as 
template for repair. However, the use of a homologous chromosome can lead to mutations, 
since homologs are often not truly identical. In particular, mitotic crossovers cause loss of 
heterozygosity in large parts of the chromosome, and these have been shown to lead to cancer 
development (Zhu et al. 1992; Luo et al. 2000). In addition, recombination between repetitive 
sequences can create large deletions, duplications, or chromosome rearrangements (Bishop 
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and Schiestl 2000). HR is essential for mammalian development, as loss of proteins required for 
HR (e.g., RAD51 or BRCA2) leads to early embryonic lethality in mice – earlier than loss of 
NHEJ proteins – likely due to role of this pathway in DNA replication (Lim and Hasty 1996; 
Tsuzuki et al. 1996; Sharan et al. 1997). 
NHEJ and HR are not the only chromosome break repair pathways available to 
eukaryotic cells. If a DSB occurs in repetitive sequence, and the 3’ ssDNA tails generated after 
end-resection have long complementary sequences (>50 bp), they can be annealed by RAD52 
(or SMARCAL1 in flies), in a pathway called single strand annealing (Bhargava et al. 2016; 
Holsclaw and Sekelsky 2017; Kelso et al. 2019). In addition, end joining can still be observed in 
NHEJ deficient cells (Boulton and Jackson 1996; Liang and Jasin 1996; Kabotyanski et al. 
1998). This form of end joining, termed generically alternative end joining (a-EJ or alt-NHEJ), 
creates deletions and insertions larger than the ones made by NHEJ, as well as chromosome 
rearrangements (Boulton and Jackson 1996; Kabotyanski et al. 1998; Feldmann et al. 2000; Ma 
et al. 2003; Yu and Gabriel 2003; Guirouilh-Barbat et al. 2004). a-EJ has also been observed in 
NHEJ proficient cells, and is the main form of end-joining in certain cells, yet normally the 
magnitude of repair associated with this a-EJ considerably lags behind NHEJ dependent repair 
(Chan et al. 2010; Van Schendel et al. 2015; Thyme and Schier 2016; Wyatt et al. 2016; 
Schimmel et al. 2017). 
Unlike NHEJ, a-EJ acts downstream of end-resection, both in yeast and mammals (Ma 
et al. 2003; Xie et al. 2009; Yun and Hiom 2009) (Fig 1.1). It is thought to serve as a back-up for 
NHEJ, on substrates that are nor amenable for binding by Ku, or for HR, with which it shares its 
starting substrate (Fig 1.1) (Ceccaldi et al. 2015; Mateos-Gomez et al. 2015; Wyatt et al. 2016; 
Feng et al. 2019). Commonly, a-EJ deletions are associated with microhomologies, short 
patches of identical sequences at both sides of the break that flank the deletion, with 
microhomology sizes ranging from 5-25 bp in yeast, to 2-6 bp in mammalian cells (Boulton and 
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Jackson 1996; Kabotyanski et al. 1998; Feldmann et al. 2000; Ma et al. 2003; Yu and Gabriel 
2003; McVey et al. 2004; Wyatt et al. 2016). For this reason, a-EJ is sometimes referred to as 
microhomology-mediated end joining (MMEJ), even though NHEJ also commonly generates 
microhomology-mediated deletions (Roth and Wilson 1986; Pannunzio et al. 2014). 
 
Figure 1.1. Double Strand Break Repair Pathways. Schematic of the three main DSB 
pathways, including a partial list of proteins involved in each step. 
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In most eukaryotes – all except for fungi –an end joining pathway dependent on DNA 
Polymerase Theta (Pol θ, gene name POLQ), termed polymerase theta-mediated end joining 
(TMEJ) (Roerink et al. 2014), accounts for the vast majority of a-EJ (Fig 1.1). This was first 
observed in Drosophila melanogaster (Chan et al. 2010), and it is particularly clear in 
mammalian cell culture, where inactivation of NHEJ and TMEJ almost completely abolishes all 
end joining (Wyatt et al. 2016; Saito et al. 2017; Zelensky et al. 2017). TMEJ is the main focus 
of this dissertation. 
Polymerase theta-mediated end joining 
Functions of DNA Polymerase Theta in chromosome break repair 
Pol θ is a large (290 kDa in humans), multi-domain protein with an N-terminal helicase-
like domain (HelD) and a C-terminal polymerase domain of the A family (PolD) (Seki et al. 
2003). In the center, it has a “middle” domain that is disordered (Black et al. 2019). The HelD 
displays ssDNA-dependent ATPase activity, yet it has at best low helicase activity (Ceccaldi et 
al. 2015; Newman et al. 2015). Pol θ is an error-prone polymerase (Arana et al. 2008) 
Pol θ was first shown to be involved in double strand break repair in Drosophila 
melanogaster (fruit flies), using a clever repair assay that relies on the generation of a double 
stranded gap by the excision of a P-element. This P-element is inside of a gene that determines 
the eye color of flies; accurate repair, by synthesis dependent strand annealing (SDSA), renders 
red-eyed flies. However, sometimes repair of this gap by SDSA fails and a mutagenic end-
joining pathway completes the repair, rendering white-eyed flies (Adams et al. 2003). This end-
joining pathway is independent of DNA ligase 4, and therefore NHEJ (McVey et al. 2004), but it 
is dependent on Pol θ (Chan et al. 2010). End-joining products are very often deletions at 
associated microhomologies and insertions for which a nearby template can be found (Adams 
et al. 2003; McVey et al. 2004). Shortly after, it was shown that Drosophila Pol θ also repairs 
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chromosome breaks generated by I-SceI, through a pathway that the authors termed synthesis-
dependent microhomology-mediated end joining (SD-MMEJ) (Yu and McVey 2010). 
Next, Pol θ was shown to be responsible for the repair of replication-associated DSBs in 
the nematode Caenorhabditis elegans (Roerink et al. 2014), during which it generates 1 bp 
microhomology deletions, using the outermost nucleotide in one of the sides of the break. Pol θ-
dependent templated insertions, similar to the ones found in Drosophila, are also observed in 
worms (Koole et al. 2014; Roerink et al. 2014; van Schendel et al. 2016). Meanwhile, 
microhomologies are slightly larger during the repair of two-ended DSBs (Van Schendel et al. 
2015; Kamp et al. 2020). Last, using murine cells, it was determined that Pol θ’s role in 
chromosome break repair is also present in mammals. Specifically, Pol θ was deemed 
important for the repair of breaks that have long 3’ ssDNA tails, reminiscent of the ones 
generated after DNA end resection (Yousefzadeh et al. 2014).  
Pol θ deficient flies and worms are hypersensitive to crosslinking agents (nitrogen 
mustard), but not to ionizing radiation (Boyd et al. 1990; Boulton and Jackson 1996; Chan et al. 
2010), suggesting that Pol θ’s role in these animals is mostly in the repair of replication-
associated damage. In both flies and worms, Pol θ further hypersensitizes homologous 
recombination mutants to ionizing radiation, indicating that TMEJ acts as a backup in the repair 
of IR-induced DSBs (Chan et al. 2010; Kamp et al. 2020). However, as stated above, Pol θ 
plays an important role on the repair of P-element induced double stranded gaps in flies, and in 
worms, TMEJ is the main form of repair of Cas9 and P-element dependent DSBs that happen in 
the germline (Chan et al. 2010; Van Schendel et al. 2015).  
Contrary to flies and worms, murine and human Polq-/- cells are hypersensitive to DSB 
inducing agents, namely ionizing radiation and the type 2 topoisomerase poison etoposide, 
indicating a role in the repair of two-ended DSBs (Yousefzadeh et al. 2014; Kelso et al. 2019). 
In addition, mammalian cells lacking Pol θ are hypertensive to drugs that generate replication-
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associated damage, such as hydroxyurea, mitomycin C or cisplatin (Ceccaldi et al. 2015; Kelso 
et al. 2019). However, in mammalian cells, the role of TMEJ in the repair of chromosome breaks 
is minor in comparison with NHEJ (Wyatt et al. 2016; Schimmel et al. 2017).  
Mechanism of polymerase theta-mediated end joining 
TMEJ’s better known starting substrate is two long, 3’ single ssDNA tails (Chan et al. 
2010; Yousefzadeh et al. 2014; Wyatt et al. 2016). These tails are generated by 5’-to-3’ 
degradation of chromosome break ends, through MRE11-dependent end resection. Once the 
substrate is generated, cells have to couple 4 steps to successfully accomplish TMEJ: 1) 
substrate recognition and recruitment of Pol θ, 2) microhomology search and annealing, 3) 
cleavage of 3’ non-homologous tails, and 4) microhomology-primed synthesis and resolution. 
It remains unknown how Pol θ is recruited to DNA ends, though a possible role for 
PARP-1 and FANCD2 has been suggested (Mateos-Gomez et al. 2015; Kais et al. 2016). Full 
length Pol θ has a high affinity for ssDNA (Kd≈10-9 M) (Black et al. 2019), yet it is much lower 
than that of the ssDNA binding protein RPA (10-11 M) (Yates et al. 2018). This, combined with 
the fact that RPA is much more abundant than Pol θ in cells (http://www.proteinatlas.org) (Uhlén 
et al. 2015), makes it very likely that the substrate Pol θ encounters in cells is RPA-bound 
ssDNA. A possible solution for this problem appears to include the HelD of Pol θ, as it can 
displace RPA from ssDNA in vitro in an ATP dependent manner (Mateos-Gomez et al. 2017). 
However, the inhibition of RPA, as well as complementation of a knock down with a 
hypomorphic version, increases Pol θ dependent telomere fusions in mouse cells, suggesting 
that RPA inhibits TMEJ despite the ability of Pol θ to displace it (Mateos-Gomez et al. 2017). 
For this reason, the nature of the biologically relevant substrate(s) of Pol θ remain unclear. In 
chapter 3, I systematically characterize the ability of Pol θ in using different DNA substrates, 
including protein-bound substrates, and non-canonical ones that may arise during replication.  
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The use of microhomologies defines TMEJ, and therefore the way microhomologies are 
found dictates the consequences of its use. This creates two problems for TMEJ: 1) It makes 
TMEJ an error-guaranteed repair pathway, as microhomology mediated repair events are 
always going to lead to loss of DNA, and 2) it establishes a sequence requirement that may or 
may not be met, as a DSB can theoretically happen in a microhomology-free region of a 
chromosome, making TMEJ useless. Chapter 2 of my dissertation describes the mechanism of 
microhomology search in detail, using a combination of chromosomal and extrachromosomal 
assays, in mouse cell culture. It shows how this search mechanism works to minimize the extent 
of deletion associated with TMEJ, as well as how Pol θ can create de-novo microhomologies 
when these are not available. 
Once the microhomology has been annealed, and before it can prime synthesis, any 
non-homologous 3’ tails need to be removed. This process could be performed by both a 3’ flap 
endonuclease or a 3’ ssDNA exonuclease. Recent work shows that Pol θ has an endonuclease 
activity, raising the possibility this protein also performing this step. Strikingly, this nuclease 
activity requires dNTPs and is inhibited by ddNTPs, therefore it is intimately linked to the 
polymerase activity (Zahn et al. 2021). This would allow for perfect coupling of the removal of 
non-homologous 3’ tails with the beginning of DNA synthesis, ensuring that only the right 
amount if DNA is cleaved. However, it remains to be seen if this activity is relevant for TMEJ in 
vivo. During chapter 3, I characterize the nuclease step of TMEJ, using DNA substrates with 
non-cleavable bonds, and show that the nuclease involved in TMEJ is likely an exonuclease.  
The last step during TMEJ is microhomology-primed synthesis. One of Pol θ’s most 
striking characteristic is its ability to prime DNA synthesis from a very small duplex − as small as 
1 bp in vitro (Hogg et al. 2012). This allows Pol θ to begin DNA synthesis using 
microhomologies as primers, turning a DSB into a ssDNA gap. The nature of Pol θ’s substrate 
has led to the assumption that Pol θ synthesizes dozens of nucleotides at a time. However, a 
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polymerase switch after a short synthesis tract, after which Pol δ takes over, has been proposed 
(Kamp et al. 2020), and might help explain how yeast can perform a-EJ without Pol θ, at the 
expense of having to use longer microhomologies.  
In vitro, Pol θ has an error rate of ≈10-3, 10-50 times higher than other exonuclease 
deficient A family polymerases (Arana et al. 2008). It displays roughly the same rate of single 
base substitution as of -1/+1 indels, and indels are most common in single nucleotide 
homopolymer runs (Arana et al. 2008). In contrast to other low-fidelity polymerases, Pol θ is 
fairly processive in vitro, being able to synthesize more than 75 nt per run, but it remains 
unknown how much Pol θ synthesizes in vivo (Arana et al. 2008). In addition, purified human 
Pol θ can synthesis across other types of DNA damage, (e.g., AP sites and thymidine glycol), 
but this has not been reported in vivo and it is possible that it is a consequence of its low fidelity 
(Seki et al. 2004; Seki and Wood 2008; Hogg et al. 2011). 
Genetics of polymerase theta-mediated end joining 
For most of its functions Pol θ seems to have a backup role, commonly behind less 
error-prone repair pathways such as HR and NHEJ. Pol θ then becomes most important when 
another repair pathway is compromised. This leads to strong genetic interactions between 
POLQ and other DNA repair genes, in some cases in the form of a lethal combined deficiency, 
or synthetic lethality. 
The genetic interaction with Pol θ that have sparked the most interest is its synthetic 
lethality with genes involved in HR, especially BRCA1 and BRCA2, due to its consequences for 
cancer development and treatment. As much as 40% of breast tumors and 50% of ovarian 
tumors are thought to be HR deficient, and heterozygous mutations in BRCA1 and BRCA2 
severely increase the chances of cancer development (Moschetta et al. 2016; den Brok et al. 
2017). The synthetic lethality between POLQ and BRCA1/2 was first described in murine and 
human cells, and has also been observed in worms (Ceccaldi et al. 2015; Mateos-Gomez et al. 
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2015; Kamp et al. 2020). Moreover, POLQ is overexpressed in BRCA1/2 deficient tumors and 
high POLQ expression correlates with poor patient survival (Higgins et al. 2010; Lemée et al. 
2010; Ceccaldi et al. 2015). For these reason, Pol θ has been identified as a promising 
therapeutic target for cancer treatment (Higgins and Boulton 2018; Schrempf et al. 2021).  
POLQ is also synthetic lethal with genes that promote NHEJ, such as KU70 and 53BP1 
in mammalian cell culture, as well as the kinase ATM (Shima et al. 2004; Wyatt et al. 2016; 
Feng et al. 2019). In addition, combined loss of POLQ and FANCD2, required for the Fanconi 
anemia pathway, renders mice inviable (Ceccaldi et al. 2015), and loss of TLS, nucleotide 
excision repair, and TMEJ renders worms that are viable, but intolerant to light (van Bostelen 
and Tijsterman 2017). The most comprehensive study to date of the POLQ genetic interaction 
landscape comes from a CRISPR screen for synthetic growth defects performed in mouse cells. 
This screen included 309 DNA damage response genes and had 140 hits, most of which had 
not been described (Feng et al. 2019). 
Chapter 4 describes a strong genetic interaction between POLQ and the Holliday 
junction resolvases SLX4 and GEN1, some of the later acting genes in HR, in Drosophila 
melanogaster and mouse cells. 
Throughout this dissertation, I answer fundamental questions regarding the mechanism 
of TMEJ, as well as its genetic relationship with HR. I hope the reader can appreciate my work 
for what it is, and for what it is not. I hope they find my experiments clearly explained, my results 
interpretable, and my conclusions compelling. More than anything else, I hope whoever reads 
the work presented here, either partially or in its totality, finds it enjoyable, and, when they’re 
done, they understand TMEJ better than they did before. If that is the case, I would be able to 
say that I am a successful scientist.  
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CHAPTER 2: MECHANISTIC BASIS FOR MICROHOMOLOGY IDENTIFICATION AND 
GENOME SCARRING BY POLYMERASE THETA1 
 
“Que el maquillaje no apague tu risa 
Que el equipaje no lastre tus alas 
Que el calendario no venga con prisas 
Que el diccionario detenga las balas” 
(May make up not turn off your laughter 
May luggage not harm your wings 
May the calendar not come with hurry 
May the dictionary stop the bullets) 
−Joaquin Sabina and Chavela Vargas 
Significance Statement 
Repair of chromosome breaks by Polymerase theta-mediated end joining (TMEJ) 
requires short sequence identities in flanking DNA (microhomologies) – a sequence-context 
constraint that is unique amongst DNA repair pathways. Though microhomologies have a 
central role in TMEJ, it has been uncertain whether an organized mechanism to identify them 
even exists. Using a combination of chromosomal and extrachromosomal substrates, we 
describe how Polymerase theta efficiently locates microhomologies when present, and creates 
them de novo when absent. We show how this generates a pattern of microhomology mediated 
end joining products that is sufficiently distinct from other end joining pathways that it can be 
used as a biomarker for TMEJ activity in cancer genomes.    
 
1 This chapter is adapted from published work. The original citation is as follows: Carvajal-Garcia J. et al. 
Mechanistic basis for microhomology identification and genome scarring by polymerase theta. Proc Natl 
Acad Sci U S A. 2020;117: 8476–8485. 
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Introduction 
DNA Double Strand Breaks (DSBs) in the chromosome are generated spontaneously, 
after exposure of cells to exogenous agents (e.g., ionizing radiation), and are induced during 
meiosis or development of the adaptive immune response (Chapman et al. 2012). DSBs are 
also generated by nucleases, especially Cas9, as intermediates in genome engineering. They 
are usually repaired by the Non-Homologous End Joining (NHEJ) pathway, which joins the two 
ends of a break with minimal processing (Waters et al. 2014b), or the Homologous 
Recombination (HR) pathway, which uses another DNA molecule as a template for repair (Jasin 
and Rothstein 2013). Impairment of either of these repair pathways – especially impairment in 
HR due to deficiency in BRCA1 or BRCA2 – leads to genome instability, which can cause cell 
death or cancer (Venkitaraman 2002).  
Another DSB repair pathway is defined by its requirement for DNA Polymerase Theta 
(Pol θ, gene name POLQ) (Chan et al. 2010; Roerink et al. 2014; Yousefzadeh et al. 2014), and 
has been termed Theta-Mediated End Joining (TMEJ). TMEJ overlaps with previously defined 
Alternative Non-Homologous End Joining (Alt-NHEJ) and Microhomology Mediated End Joining 
(MMEJ) pathways (Boulton and Jackson 1996; Kabotyanski et al. 1998; Ma et al. 2003), though 
the extent these definitions overlap is not clear. In mammals, TMEJ is both more frequent and 
essential for viability in cells deficient in NHEJ (Wyatt et al. 2016; Saito et al. 2017; Zelensky et 
al. 2017) or HR (Ceccaldi et al. 2015; Mateos-Gomez et al. 2015; Feng et al. 2019). A specific 
requirement in BRCA-deficient contexts for Pol θ has identified this protein as a therapeutic 
target in BRCA-deficient breast cancers (Higgins and Boulton 2018). However, TMEJ 
mechanism is not well understood, and it is important to determine its role and relevance in 
NHEJ and HR proficient cells. 
TMEJ and HR pathways engage a common intermediate, the 3’ ssDNA tails generated 
after resection of chromosome breaks (Yousefzadeh et al. 2014; Wyatt et al. 2016). Pol θ aligns 
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these tails and anneals small 2-6 bp patches of complementary sequence (microhomologies), 
which is followed by removal of at least one nonhomologous tail, then microhomology-primed 
synthesis sufficient to resolve remaining gaps (Fig. 2.1A) (Yousefzadeh et al. 2014; Kent et al. 
2015). Differing location and frequency of microhomologies at different break sites is thus 
expected to have an impact on pathway outcome. At a minimum, the extent of deletion 
associated with repair by TMEJ will be determined by the locations of microhomologies relative 
to the break site, and especially the means by which these microhomologies are identified. 
Breaks in microhomology-poor regions of the genome could also lead to impaired TMEJ activity, 
and consequently cell death or cancer-causing genome rearrangements. 
Here we explore the basis for the microhomology identification step in TMEJ by 
systematically defining Pol θ-dependent repair products at a series of Cas9-induced 
chromosome breaks, where the break sites were chosen to possess varied density of break-site 
proximal microhomologies. We then explored the mechanistic requirements for TMEJ that are 
suggested by these results using an extrachromosomal substrate assay, as this latter strategy 
allows for unambiguous assessment of TMEJ activity on systematically varied substrates. Our 
results support a bi-directional scanning mechanism that mitigates deletion associated with 
TMEJ, as this scanning mechanism efficiently identifies microhomologies only when they are 
within 15 bp of either side of the break site. Break site locations within the genome that are 
depleted of microhomologies within 15 bp can nevertheless still be effectively repaired by TMEJ. 
In such contexts, TMEJ requires one or more cycles of aborted synthesis that generate long 
microhomologies de novo, which now better support processive synthesis. These latter products 
possess locally templated insertions that are highly characteristic of this pathway, and are 
consequently an effective biomarker for Pol θ/TMEJ activity in breast cancer genomes. 
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Figure 2.1. Characterization of Pol θ dependent deletions after a chromosome break. A) 
Steps required for TMEJ, emphasizing a critical role for microhomology identification. B) The 
probabilities of finding 2-6 bp (blue) or 3-6 bp (black) microhomologies (MH) were determined 
for sets of 100,000 randomly generated pairs of sequences of increasing size (flanking DNA 
sequence), from 2-33 nucleotides. C) Cas9 targeted to 5 different break sites in the Rosa26 
locus (R26A-E) were separately introduced into transformed mouse embryo fibroblasts 
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(MEFs) from POLQ-/- deficient mice engineered to express human POLQ or not. Chromosome 
break repair products were recovered 24 hours later, amplified, and characterized by next 
generation sequencing (NGS). D) and E) The difference in the fraction of repair products with 
noted size of deletion (D) or microhomology (E) in POLQ expressing cells vs. POLQ-/- was 
averaged across all 5 break sites tested. F) Filled circles denote the location of all 
microhomologies 2 bp or more relative to the break site for all 5 break sites, with 
microhomology size noted according to the size of the filled circle. Deletions enriched in cells 
expressing wt POLQ vs. POLQ-/- cells in triplicate experiments are shown in orange, and 
were identified using a two tailed t-test and the Benjamini-Hochberg procedure to adjust p-
values for multiple comparisons, with a false discovery rate of 0.05. 
 
Materials and Methods 
Cell lines 
Cells were incubated at 37 °C, 5% CO2 and cultured in DMEM (Gibco) with 10% Fetal 
Bovine Serum (VWR Life Science Seradigm) and Penicillin (5 U/ml, Sigma). These lines and 
variants described below were confirmed to be free of mycoplasma contamination by a qPCR 
(Janetzko et al. 2014) with a detection limit below 10 genomes/1ml. Cell lines were additionally 
selected at random for third party validation of PCR results using Hoechst staining (Battaglia et 
al. 1994). 
Polq-/- Mouse Embryonic Fibroblasts (MEFs) were generated and immortalized with T 
antigen as described (Yousefzadeh et al. 2014) from Polq-null mice generated by conventional 
knock-out (Shima et al. 2004) that were obtained from Jackson Laboratories and maintained on 
a C57BL/6J background. Pol θ was expressed by introducing wt POLQ human cDNA by 
lentiviral infection, with cells maintained in medium containing 4 μg/ml of puromycin.  
Extrachromosomal assay 
As in a previous report (Wyatt et al. 2016), extrachromosomal substrates consist of a 
557 bp core DNA duplex ligated to head and tail caps with end structures that were varied as 
described in each figure. A core fragment generated by PCR was digested with BsaI, and 
extrachromosomal substrate assembled by ligation of this BsaI digested core fragment with a 5-
fold excess of head and tail caps with T7 ligase (NEB). Excess cap was removed using 
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QIAquick PCR Purification Kit (QIAGEN), and efficient substrate assembly and removal of 
excess cap confirmed by analytical gel electrophoresis. 75 ng of these substrates were 
electroporated into 200,000 cells with 1 ug of pMAX-GFP (Lonza) using the Neon system 
(Invitrogen) in a 10 ul tip with a 1,350 V, 30 ms pulse (three pooled electroporations formed a 
biological replicate) and incubated for 1 h at 37°C. Cells were washed with Hank’s balanced 
saline solution and incubated with 25U of Benzonase (Sigma) for 10 min at 37°C. DNA was 
purified using the QIAamp DNA mini kit (QIAGEN), and products analyzed using SYBR green 
qPCR or a 30-cycle end point PCR and run on a 6% polyacrylamide gel. Each experiment 
consisted of three replicates of the above protocol. Quantification of gel bands was done with 
ImageQuant 8.1 
Chromosomal assay 
Chromosomal DSB repair assays were performed using Cas9-gRNA RNP complexes 
assembled from Cas9 purified after overexpression in bacteria (Lin et al. 2014) (Addgene 
#69090), as well as annealed tracrRNA and target-specifying crRNA (see table 1.1 for gRNA 
target sequence) with stabilizing modifications (Alt-R, IDT). 7 pmol of Cas9 were incubated at 
room temperature with 8.4 pmol of annealed crRNA+tracrRNA for 30 mins, and electroporated 
into 200,000 cells with 32ng of pMAX-GFP as described above (three pooled electroporations 
formed a biological replicate). Cells were incubated for 24 hours and DNA was harvested with 
the QIAamp DNA mini kit (QIAGEN). Each experiment consisted of three biological replicates. 
DNA equivalent to 60,000 genomes was amplified for 24 cycles using primers purified by 
polyacrylamide gel electrophoresis (IDT) that included a 6 bp barcode, a spacer sequence of 
varying length (1-8 bp) to increase library diversity, and 21 (fwd primer) or 22 (rev primer) bp of 
Illumina adapter sequence. Amplicons were then purified using a 2% agarose (Lonza) gel and 
the QIAquick Gel Extraction Kit (QIAGEN), recovered DNA amplified with secondary NGS PCR 
primers for 5 cycles, and purified with AMPure XP beads (Beckman Coulter). Libraries were 
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sequenced using a 300-cycle MiniSeq Mid Output Kit (R26A) or an iSeq 100 i1 Kit (R26B-E), 
including 20% of PhiX Control v3 DNA (Illumina). The number of reads analyzed per sample is 
reported table 1.2. Data was analyzed using CLC Genomics Workbench 8 and Microsoft Excel.  
Junctions were characterized by independently identifying within each read the least-
deleted 10 nucleotide match to sequence upstream of the break site, then the least-deleted 10 
nucleotide match to sequence downstream of the break site. When present, microhomologies 
were defined as the overlap between upstream and downstream matches, and insertions were 
defined as non-matching sequences separating upstream and downstream matches. Further 
analysis of junctions employed a “reconstructed junction”, consisting of a concatenation of the 
10 bp upstream flank match (including microhomology, when present), inserted sequence 
(when present), and the 10 bp downstream flank (excluding microhomology, when present).  
Table 1.1: Break site sequences 
Locus gRNA sequence + PAM  Chr. 6 location 
R26A ACTCCAGTCTTTCTAGAAGATGG 113,068,731 
R26B CCGCCTCGGAGTATTTTCCATCG 113,068,958 
R26C CATGGATTTCTCCGGTGAATAGG 113,071,870 
R26D CCTATTCACGTAACCAGGTTAGC 113,075,531 
R26E CCACAAATCGAGGCTGTAGCTGG 113,069,295 
gRNA sequences + PAM (underlined) and sequence location in the mouse chromosome 6 for 
all 5 break sites tested. 
 
Table 1.2: Sequencing reads 
Genotype Break site Replicate 1 Replicate 2 Replicate 3 
Polq-/- + POLQ 
R26A 31,617 26,815 19,817 
R26B 64,880 9,713 140,496 
R26C 135,961 11,6342 140,111 
R26D 172,163 17,3076 175,362 
R26E 185,531 207,476 247,170 
Polq-/- 
R26A 25,726 18,706 18,636 
R26B 21,176 141,187 153,290 
R26C 146,179 148,533 164,259 
R26D 146,713 138,013 151,899 
R26E 144,012 132,219 93,086 
Number of reads analyzed from each biological replicate for the two genotypes in the five loci 
tested. 
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For Figs. 2.5 and 2.6, insertions were characterized as templated direct repeats if the 
first 5 nucleotides of the inserted sequence could be mapped to sequence within 50 nt 
downstream of the break site (“downstream direct repeats”) or the last 5 nucleotides of the 
inserted sequence could be mapped to sequence 50 nt upstream of the break site (“upstream 
direct repeats”). Insertions were characterized as templated inverse repeats if the 5 last 
nucleotides of the inserted sequence could be mapped to the reverse complement of sequence 
within 50 nt downstream of the break (“downstream inverse repeats”) or if the 5 first nt of the 
inserted sequence could be mapped to the reverse complement of the 50 nt upstream of the 
break (“upstream inverse repeats”). We included cases of insertions < 5 nt as templated if 
additional templated insertions could be inferred due to involvement of 2o microhomologies in 
resolution (i.e. when sequence downstream of the insertion extended the identity that was 
detected in the proposed template to a total of 5 nt or more). When multiple flanking sequences 
with 5 nt or more of identity to the insert were identified, we selected as template the flanking 
sequence with the largest match. We excluded insertions where the first inserted nucleotide was 
substituted, relative to the reference, but subsequent inserted sequence was identical to 
reference; such products could be identified in control experiments as substitutions made during 
sample amplification.  
Direct repeat 1o microhomologies in TINS with template in downstream DNA were 
determined by assessing the extent of identity between nucleotides in flanking DNA upstream of 
the insert when compared to nucleotides upstream of the identified template. Conversely, direct 
repeat 1o microhomologies in TINS with template in upstream DNA were determined by 
assessing the extent of identity between nucleotides in flanking DNA downstream of the insert 
when compared to nucleotides downstream of the identified template. 2o microhomologies were 
assessed similarly, except we assessed the extent of identity when comparing sequences on 
the opposite sides of the insert and identified template. As noted in the legend to Fig. 2.6F, we 
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assessed 2o microhomologies only for TINS less than 5 nucleotides, to exclude significant 
contribution of TINS where there was more than one round of synthesis. (e.g., Fig. 2.7B).  
For Fig. 2.9 and 2.10, mutations from 569 whole genome sequenced breast cancers 
were obtained from the International Cancer Genome Consortium (ICGC) data portal 
(https://dcc.icgc.org/api/v1/download?fn=/release_26/Projects/BRCA-
EU/simple_somatic_mutation.open.BRCA-EU.tsv.gz). Mutation lists were sorted by sample, 
chromosome and position prior to removing duplicate mutation entries. All insertion mutations 
and multiple nucleotide variants (MNV, which involve deletion of a sequence and insertion of a 
new, non-reference sequence) were extracted. For MNVs, the inserted sequences were 
compared to the deleted reference sequences to confirm accurate determination of the position 
the MNV event. For a small portion of MNVs, several nucleotides at either the 5’ or 3’ portions of 
the inserted sequences matched the sequence of the reference. These matching sequences 
were removed from the insertion sequence and the position of the MNV corrected prior to 
subsequent analysis. 100 nt of DNA sequence flanking each mutation was retrieved from the 
hg19 reference sequence for the human genome. Templated insertions (TINS) events among 
the breast cancer mutations were defined as above, except we considered only 30 nt of flanking 
DNA sequence as possible template. We also excluded templated insertions in which the 
inserted sequence immediately followed the template (tandem repeats). Breast cancer 
mutations were additionally stratified by BRCA1 and/or BRCA2 deficiency as determined by a 
germline mutation or hyper methylation in either gene as reported (Wen and Leong 2019). 
Original data files describing the BRCA1/2 status of ICGC characterized tumors can be found at 
https://github.com/wenweixiong/BRCA2018. We obtained gene expression data for the 
evaluated tumors as log(2) transformed fragments per kilobase per million reads (FPKM) RNA-
seq from Supplementary Table 7 of (Nik-Zainal et al. 2016). We normalized POLQ log(2) FPKM 
counts according to housekeeping gene expression data as follows: for each of three 
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housekeeping genes (TBP, HPRT, and GAPDH), we determined the difference between the 
log(2) FPKM counts for each tumor from the mean counts for the whole set, then averaged 
these three numbers for each tumor to determine normalization factors, which were then 
subtracted from the POLQ log(2) FPKM counts for each tumor. 
Statistical analysis 
To identify microhomology associated deletions (MHD) significantly depleted in cells 
lacking POLQ, we first identified the set of deletion products where each product was 
represented at a mean frequency greater than 1x10-5 in cells expressing POLQ. We then 
compared the frequencies for each product from 3 biological replicates for both POLQ-/- cells vs. 
POLQ-/- + POLQ cells using a two tailed t-test without sample pairing, and employed the 
Benjamini-Hochberg method with a false discovery rate of 0.05 to limit false positives that arise 
from making multiple comparisons. Calculations were performed in Microsoft Excel. Other 
experiments employed statistical tests as indicated in the figure legends using GraphPad 
Prism 8. 
Data availability 
All raw fastq files are available at NCBI SRA (accession number PRJNA605803). The 
tables of results after additional analysis of the deindexed junctions are available upon request. 
Results 
Characterization of Pol θ mediated deletions after a chromosomal break 
Prior studies indicate efficient Pol θ mediated synthesis activity requires 
microhomologies of 3 bp or more (Kent et al. 2015; Wyatt et al. 2016; He and Yang 2018). To 
assess how this requirement could impact repair we employed in silico modeling to determine 
the likelihood of finding such microhomologies as a function of increasing distance from the 
break site. The frequency of a 3 bp or more microhomology in a set of random pairs of break 
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site flanking sequences is 64% when considering 10 bp of flanking sequence, and 93% when 
considering 15 bp. Inclusion of 2 bp microhomologies is sufficient to increase the frequency 
within 10 bp to 99% (Fig. 2.1B), though as discussed below, 2 bp microhomologies are less able 
to promote processive repair synthesis by Pol θ.  
To address how these limitations impact TMEJ, we focused on 5 break sites (termed 
R26A through R26E) within a 7 kb region that varied according to the density and length of 
microhomologies near the break site (Fig. 2.2A). In particular, two closely located sites (within 
500 bp) are unusually rich (R26A) vs. unusually poor (R26E) in terms of the availability of 
microhomologies within 15 bp.  
We generated chromosome breaks at each of the 5 break sites by direct introduction of 
appropriately targeted S. pyogenes Cas9 ribo-nucleoprotein complexes into T antigen 
transformed mouse embryo fibroblasts (MEFs). We harvested cells 24 hours later in an attempt 
to mitigate the contribution of repair after excessive non-specific degradation of DNA ends, 
while ensuring that repair products with insertions and deletions accumulate at the majority of 
chromosomes. We amplified products without a phenotype-based screen, to ensure product 
spectra is limited only by whether the products can be amplified (i.e., retains primer sequences), 
then characterized products by next generation sequencing (Fig. 2.1C).  
We first analyzed simple deletion products; i.e., deletions of flanking DNA without 
inserted sequences. We systematically identified those products enriched in human POLQ 
expressing MEFs (POLQ-/- MEFs complemented by expression of POLQ cDNA), relative to the 
POLQ-/- deficient isogenic parental cell line (Yousefzadeh et al. 2014). Highly enriched products 
consisted exclusively of deletions <30 bp (Fig. 2.1D) that were associated with 2-6 bp 
microhomologies (microhomology associated deletions; MHD) (Fig. 2.1E). The microhomologies 
chosen are also largely restricted to those within 10-15 bp of either side of the break site (Fig. 
2.1F; Table 1.3). Moreover, nearly all microhomologies present less than 10 bp from termini 
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(7/8) are significantly enriched (Fig. 2.1F). In accord with a restriction to 15 bp flanking the break 
site, we observed no significantly enriched MHD in repair products recovered from breaks at 
R26E, the site with few break-site proximal microhomologies (Fig. 2.2A; Table 1.3). More 
broadly, MHD associated with large deletions (>15 bp from either end) are actually suppressed 
by Pol θ/TMEJ for all 5 break sites tested, including R26E (Fig. 2.2B). TMEJ thus promotes 
more accurate repair. 
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Figure 2.2. TMEJ promotes short MHD A) Cumulative number of microhomologies larger 
than 1 bp at the noted distance to the break site. Distance to the break site corresponds to 
the largest of the two distances (upstream and downstream) from the beginning of the 
microhomology to the break terminus. B) Fraction of repair corresponding to deletions with 
microhomologies 2 bp or more and located more than 15 nt from both sides of the break site 
in POLQ-/- cells that expressed POLQ (orange) or not (black). Bar represents the means and 
error bars SEM for 3 biological replicates. Statistical significance was assessed by one-way 
ANOVA with Bonferroni correction to account for multiple comparisons; *, p<0.05. 
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adjust p values 
for multiple 
comparisons, 
with a false 
discovery rate of 
0.05.  
R26A 
0 0 3 0.057557 
6 11 6 0.023439 
10 0 2 0.006968 
3 5 0 0.000259 
R26B 
4 10 3 0.032344 
3 0 2 0.017555 
1 11 2 0.008442 
6 6 2 0.006746 
3 4 1 0.004777 
7 2 2 0.004391 
8 4 1 0.00411 
6 9 1 0.003844 
2 6 0 0.001395 
R26C 
2 4 2 0.036814 
9 9 0 0.000588 
11 6 0 0.00058 
3 7 0 0.000381 
15 3 0 0.000305 
R26D 
4 7 2 0.021654 
2 4 2 0.014109 
1 4 1 0.008736 
2 1 0 0.006699 
0 1 0 0.005915 
2 1 1 0.004951 
9 4 2 0.004299 
4 0 1 0.004095 
8 4 1 0.002299 
1 1 0 0.0018 
9 1 0 0.001155 
2 41 3 9.37E-05 
R26E 6 6 0 0.00366 
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Mechanism of microhomology search 
We addressed the mechanistic basis for microhomology choice described above by 
employing a cellular TMEJ assay that allows for systematic variation of the substrate. This 
assay employs extrachromosomal “pre-resected” substrates, consisting of double stranded DNA 
fragments with ends that have 70 nt single stranded DNA 3’ tails. The pre-resected tails block 
engagement of KU-dependent NHEJ, thus joining relies exclusively on Pol θ for efficient repair 
(joining efficiency reduced over 10-fold in Polq deficient cells; e.g., Fig. 2A) (Yousefzadeh et al. 
2014; Wyatt et al. 2016). 
We first assessed if a distance restriction on the ability of Pol θ to identify 
microhomologies helped explain the chromosomal repair results described above. We 
compared activity on substrates where a defined microhomology was present at increasing 
distance from the two 3’ termini, and replaced sequence downstream (3’) of the embedded 
microhomology with poly(dT) tracts, to ensure the absence of even trivial alternate 
microhomologies closer to the 3’ terminus. These substrates were introduced into the same 
isogenic MEFs with or without POLQ expression as described above, and repair assessed by 
quantifying the efficiency of repair, as well as by characterizing repair product structure (Fig. 
2.3A).  
TMEJ was similarly efficient when a 4 nt microhomology was embedded 2 or 10 nt from 
both 3’ termini, but was only 15% of maximal levels when the microhomology was embedded 15 
nt (identified as 2/2, 10/10 and 15/15; distances refer to the size of nonhomologous tail after 
microhomology alignment) (Fig. 2.3A). TMEJ was also reduced if only one copy of the 
microhomology was located 15 nt distal to the break (2/15; Fig. 2.4A). In accord this result, we 
rarely observe significant enrichment by POLQ expression of chromosomal MHD that are 
similarly asymmetric (Fig. 2.1F; considering 9 potential MHD with <3 deleted from one flank, and 
9-15 bp from the other, only 2 are enriched/orange). These observations exclude a mechanism 
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where one end is fixed, and search proceeds inward from the other (i.e., the microhomology 
search typically progresses inward from both termini, rather than only one).  
 
Figure. 2.3. Mechanistic basis for microhomology 
usage by Pol θ. A) 691 bp dsDNA substrates with 70 
nt 3’ ssDNA tails possessed microhomologies of 4 
and 6 bp (4 bp MH, 6 bp MH) that were located in 
ssDNA tails 2, 10, 14, 15, and 30 nt from both head 
and tail 3’ termini (e.g. 2/2). Sequence 3’ of the 
microhomology was replaced with polyT(n) tracts. 
Substrates were introduced into the MEFs with and 
without POLQ expression described above. Head to 
tail end joining efficiencies in recovered DNA were 
determined by qPCR, and normalized to the joining 
efficiency observed using the 2/2 substrate. Statistical 
significance was assessed by one-way ANOVA with 
Bonferroni correction to account for multiple 
comparisons; ns, not significant; *, p <0.05. 
Experiments on substrates with 4 bp MH and 6 bp 
MH substrates were performed independently. 
Electrophoresis of a representative end point PCR is 
shown to confirm preferential usage of terminal 4 and 
6 bp MHs for repair (bottom panel). B) Identical 4 bp 
MHs were located 2 nt and 10 nt from both head and 
tail 3’ termini and introduced into the cells described 
above. Products were amplified and characterized by 
electrophoresis (representative experiment shown); 
the mean relative amounts of noted species were 
determined for three independent experiments. Error 
bars denote the SEM. 
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A larger 6 bp microhomology allowed for partial rescue of repair efficiency when located 
more than 10 bp away (14/14; 75%, relative to 2/2), but repair was abolished for even this larger 
microhomology when it was located 30 bp distal from both 3’ termini (Fig. 2.3A). Therefore, the 
limitation of Pol θ-dependent chromosomal MHD to within 15 bp of break sites described above 
(Fig. 2.1F) is at least in part due to a reduced ability of Pol θ to use microhomologies further 
away (Fig. 2.3A). 
 
Figure 2.4. TMEJ favors a symmetric 
microhomology search A) Joining 
efficiency was calculated as in Fig. 2 for a 
substrate with a microhomology located 2 
nt away from the 3’ terminus for both 
head and tails ends (2/2), as well as a 
substrate with a microhomology 2 nt from 
the head 3’ terminus and 15 nt from the 
tail 3’ terminus (2/15). Bars represent the 
mean and error bars SEM for 3 biological 
replicates. Statistical significance was 
assessed by one-way ANOVA with 
Bonferroni correction to account for 
multiple comparisons B) Schematic of two 
Pol θ dependent MHD identified in 
chromosomal repair products at the break 
site R26D. The fraction of repair products 
enriched by POLQ expression was 
calculated as in Fig 2.1 SEM is shown in 
parenthesis for 3 biological replicates. 
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Microhomologies that are 2 nt vs 10 nt from both 3’ termini are used with similar 
efficiencies when they are the most 3’ proximal microhomologies present. We considered next 
whether they are also functionally equivalent when in competition. We designed a single TMEJ 
substrate where both ssDNA tails had two copies of the same microhomology, with one copy 
located 2 nt from the 3’ terminus, and the other copy 10 nt from the 3’ terminus (2/2+10/10) (Fig. 
2.3B). Strikingly, the most proximal pair of microhomologies (2/2) was employed 5 times as 
frequently as any of the more distally located microhomologies (10/10, as well as 10/2 and 2/10) 
(Fig. 2.3B). Analysis of chromosomal data similarly reflected a strong preference for the more 3’ 
proximal of two equivalent microhomologies (Fig. 2.4B). These results are indicative of a 
mechanism that “scans” for available microhomologies, initiating from the 3’ terminus. 
Pol θ generates locally templated insertions 
The experiments above focused on simple deletions (i.e., loss of flanking DNA without 
inserted sequences). We considered next the subset of chromosomal repair products that 
contain inserted sequence, whether such products contained deletion of flanking sequence or 
not. Insertion lengths varied between 1 and 157 bp. Pol θ increases the fraction of repair 
products with insertions over 2 bp, most clearly those between 3 and 6 bp (Fig. 2.5A). For most 
of these products, inserted sequences can be defined as repeated relative to nearby flanking 
DNA sequence (typically within 30 bp; Fig. 2.5B). These are best explained if the insertions are 
products of template-dependent synthesis (Templated insertions; TINS) (Yoshida et al. 1995; 
Jäger et al. 2000; Khodaverdian et al. 2017). Most of the remaining insertions enriched in POLQ 
expressing cells (grey in Fig. 2.5A) likely also employ a local template, but the length of the 
synthesis tract was not sufficiently long to pass the 5-nucleotide minimum value we employed to 
exclude Pol θ-independent insertions. A small fraction (<0.1% of total repair) of insertions 
employed template distal to the break site, including other chromosomes. We identified two 
classes of TINS: synthesis of 5 bp or more of sequence that is directly repeated, relative to 
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flanking DNA (direct repeats, DR), or synthesis of 5 bp or more of sequence that is the reverse 
complement of flanking DNA (Inverse Repeats, IR) (Fig. 2.5C). The former is consistent with a 
primary round of synthesis (1o synthesis) initiated from one broken, resected end, using the 
second resected end as a template (intermolecular synthesis), while the latter is consistent with 
1o synthesis that was initiated from a hairpin (intramolecular synthesis).  
The frequency of TINS varied widely across different break sites. Notably, TINS 
frequency was almost undetectable at R26A, the break site that is unusually rich in break 
proximal microhomologies (Fig. 2.6A). In contrast, TINS accounted for the only significant class 
of Pol θ-dependent events at R26E (Fig. 2.6A), where flanking sequence is poor in 
microhomologies. 
Decreased availability of break site-proximal microhomologies thus correlates with both 
decreased MHD and increased TINS. Prior work argues that both MHD and TINS involve 
microhomology-mediated synthesis (Chan et al. 2010; van Schendel et al. 2016). However, 
MHD are generated after a single round of alignment-directed synthesis that was sufficiently 
processive to complete repair. By comparison, TINS are generated when the initial round of 
alignment-directed synthesis fails before repair is complete, and is followed by one or more 
additional rounds of alignment and synthesis (Fig. 2.5C). We sought to address next whether 
we can identify a mechanistic basis for failed synthesis. 
We first confirmed that like MHD, the 1o round of synthesis in TINS favors alignment at 
microhomologies; the frequency of use of microhomologies 2 bp or more in this context is higher 
than would be expected by chance (25%, vs. 7%) (Fig. 2.6B). Preference for microhomologies 
is also sufficient to explain the non-random siting of synthesis initiation that is readily apparent in 
a map of the sources of templated insertions (Fig. 2.5B). However, microhomologies associated 
with TINS are generally shorter, relative to those associated with MHD, where 93% of MHD are 
associated with microhomologies 2 bp or more (Fig. 2.6B).  
31 
 
Figure 2.5 Pol θ generates locally 
templated insertions. A) The difference 
in the fraction of repair products with 
noted size of insertion in POLQ 
expressing cells vs. POLQ-/- was 
averaged across all 5 break sites. 
Insertions were defined as having 5 bp or 
more direct or inverse repeated sequence 
(DR, cyan; IR, blue) relative to flanking 
DNA (see also panel C). B) The relative 
abundance of insertions with 5 bp or more 
repeated sequence is plotted according to 
the location of the repeat within flanking 
DNA for both DR (cyan) and IR (blue) 
insertions. C) Model for generating direct 





Figure 2.6. Characterization of TINS. A) Fraction of repair events enriched by POLQ 
expression that generated deletions with 2 bp or more of microhomology within 15 bp of the 
break site (MHD, red), or a templated insertion larger than 2 bp (TINS, blue), for each of the 5 
break sites tested. Bar represents the mean and error bars SEM from 3 biological replicates. 
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B) Average fraction of junctions associated with the indicated microhomology sizes in 
deletions significantly enriched by POLQ expression (Deletions), in insertions larger than 2 bp 
and directly repeated relative to flanking DNA (TINS), and as would be expected by chance, if 
microhomologies played no role (expected). C) Fraction of products with insertions of 5 bp or 
more sequence directly repeated relative to flanking DNA, comparing total length of 
synthesized nucleotides (insertion size; cyan) to the length of the first round of synthesis (1o 
synthesis; dark blue). D) Percent AT content in TINS defined as in C) (blue), compared to AT 
content in the 100 bp surrounding the break site for each locus (locus; white). Bar represents 
the mean and error bars SEM for 3 biological replicates. Statistical significance was assessed 
by a one-sample t test on each locus individually; ns, not significant; *, p<0.05. E) Model for 
the role of TINS in generating de novo (2o) microhomologies. F) Fraction of repair events 
associated with the indicated microhomology sizes for products with 4 or 5 bp of TINS in 
R26E, for 1o microhomologies vs. 2o microhomologies (see also panel E). 
 
We further probed this correlation using specific microhomologies. We identified three 
different microhomologies that varied in size, but which were similarly located relative to the 
break site, then compared the relative frequencies of the two classes of events for each of the 
microhomologies (Fig. 2.7A). A long, 6 bp microhomology (AGTCTT) in R26A led to MHD 254-
fold more often than TINS. An intermediate-sized 3 bp microhomology (TCC) in R26B lead to 
MHD 75-fold more frequently than TINS. Finally, a short 2 bp microhomology (AT) in R26E 
generated MHD only 1.66-fold more frequently than TINS. A given microhomology consequently 
contributes to both classes of Pol θ dependent events, but the extent that MHD is favored over 
TINS decreases as the size of the initial microhomology decreases. 
We conclude the probability of an aborted round of synthesis (and resolution with TINS) 
is partly reliant on instability in the alignment of the 1o microhomology. Two characteristics of 
TINS argue the processivity of synthesis after initial alignment also has a critical role in 
determining whether this round of synthesis aborts. 1o synthesis tracts in insertions are short – 
rarely more than 10 bp (Fig. 2.6C). Longer insertions, while present (insertion size, Fig. 2.6C), 
involve more than one round of templated insertions (e.g., Fig. 2.7B). In addition, the AT content 
of TINS was enriched relative to flanking DNA for all 5 break sites tested (Fig. 2.6D). This 
presumably reflects less effective stabilization of alignments when synthesis proceeds through 
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AT rich flanking sequence (relative to GC rich templates), more frequent disruption of the 
alignment, and consequently a requirement for a second alignment and round of synthesis. 
Prior work has noted how unsuccessful rounds of synthesis in TINS can generate 
microhomologies de novo (2o microhomologies), and these 2o microhomologies can be 
employed in alignments that prime the next round of synthesis (Fig. 2.6E) (Chan et al. 2010; Yu 
and McVey 2010). We show here that these 2o microhomologies were typically longer (57% >1 
bp) than the initial, failed 1o microhomology driven alignment (16% >1 bp) (Fig. 2.6F). TINS is 
thus effectively an adaptive mechanism – in microhomology-poor regions it generated new, 
more stable microhomologies that increased the likelihood of successful repair. 
We employed extrachromosomal substrates to directly test if TINS are a function of both 
reduced size of 1o microhomology, as well as the AT content of the template flanking the 
microhomology. We assessed the importance of flanking DNA by generating two substrates 
with the same short, 3 bp microhomology (TAG), but highly divergent levels of flanking AT 
content; a substrate with 80% AT content downstream of the microhomology, vs. a substrate 
with 80% GC content downstream of the microhomology (Fig. 2.8A). When flanking DNA was 
AT rich, joining was 25% as efficient as when flanking DNA was GC rich (Fig. 2.8B), and repair 
products generated using the substrate with AT rich flanking DNA more often possessed TINS 
(Fig. 2.8C). As with chromosomal repair products, both direct repeat and inverted repeat TINS 
were frequent. These results are consistent with a critical role for ongoing synthesis in 
stabilizing a given alignment, and enabling productive repair. We further used a variant of the 
substrate with AT rich flanking DNA with a longer microhomology (6 bp) (Fig. 2.8A). The longer 
1o microhomology was sufficient to promote higher joining efficiencies (Fig. 2.8B), as well as 
lower frequencies of TINS (Fig. 2.8C), relative to both of the substrates (AT rich and GC rich) 
with 3 bp microhomologies.  
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Fig. 2.7. TINS involve multiple rounds of microhomology-primed synthesis A) The 
fraction of repair products enriched by POLQ expression comparing MHD vs. TINS and 
number of different TINS identified (#) for each of three 1o microhomologies of differing 
length; a 6 bp AGTCTT microhomology in R26A, a 3 bp TCC microhomology in R26B, and a 
2 bp AT microhomology in R26E). The location of the 1o microhomology with respect to the 
break site is indicated as upstream deletion/downstream deletions). B) Generation of a repair 
product consistent with three microhomology primed synthesis events. Primary (1o) 
microhomology is shown in red, 1o round of synthesis in dark blue, and secondary (2o) round 
of synthesis in cyan. 
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Figure 2.8. Frequency of TINS is 
dependent on both microhomology size 
and template AT content. A) TMEJ 
substrates possessed the same 3 bp 
microhomology followed by 20 bp of 
template that was either 80% AT (3 bp-AT) 
or 80% GC (3 bp-GC), or which possessed 
the 80% AT content template, but a longer 
6 bp microhomology (6 bp-AT). The 
efficiency of cellular TMEJ (B) was 
determined for each substrate as in Figure 
2A, and product structures (C) were 
characterized by next generation 
sequencing (NGS). B) Joining efficiency 
was determined by qPCR and normalized 
to results using the 6 bp-AT substrate, and 
compared to results using the original 2/2 
4bp (4bp) substrate described in figure 2A. 
Bars represents the mean and error bars 
the standard error of the mean (SEM) from 
3 biological replicates. Statistical 
significance was assessed by one-way 
ANOVA with Bonferroni correction to 
account for multiple comparisons; ns, not 
significant; *, p<0.05. C) TMEJ products 
were amplified and characterized by 
sequencing as MHD if possessing 
deletions at 2 bp or more of 
microhomology, DR if products contain 5 
bp or more of templated (directly repeated, 
DR) synthesis, or 5 bp or more of 
templated (inversely repeated, IR) 
synthesis. Other represents products 
inconsistent with MHD or TINS. 
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TINS genomic scars are a biomarker for increased TMEJ activity in BRCA mutated 
cancers 
MHD are often – though not always (see e.g., Fig. 2.6A) – the most frequent Pol θ-
dependent repair products for a given chromosome break, and serve as a biomarker for TMEJ 
activity (Feng et al. 2019). However, some MHD are favored during NHEJ (Fig. 2.9A), while yet 
others can be suppressed by Pol θ (Fig. 2.2B). By comparison, TINS are a more characteristic 
product of Pol θ-dependent repair (Fig. 2.9B), and consequently has been proposed as a more 
effective biomarker for Pol θ/TMEJ activity (Schimmel et al. 2019). To address this possibility, 
we assessed whether it was possible to correlate the frequency of TINS with POLQ expression 
levels in the genomes of breast cancers previously sequenced by ICGC (Nik-Zainal et al. 2016) 
and made publicly available at https://dcc.icgc.org/releases/release_26/Projects/BRCA-EU. We 
determined that TINS were higher in the 65 cancers with high POLQ expression (top quartile), 
relative to the 66 cancers with low POLQ expression (bottom quartile) (p<0.0001, Mann-
Whitney test) (Fig. 2.10a). Notably, we observe a similar correlation of TINS with POLQ 
expression (p=0.0002, Mann-Whitney) after excluding cancers with germline mutations in 
BRCA1 or BRCA2, a possible confounding issue (Fig. 2.9C) (discussed in the following 
paragraph). Moreover, inserted sequences identified as TINS in cancer genomes were AT rich, 
relative to flanking DNA (Fig. 2.9D), in accord with our description of Pol θ-dependent TINS at 
Cas9-induced double strand breaks (Fig. 2.6D). 
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Figure 2.9. TINS can be used as a marker of Pol θ activity in tumors A) Structure of a 
repair event in R26A characterized as deletion of a terminal 3 bp microhomology (in orange), 
with the fraction of repair represented by this product noted for wild type, POLQ-/- and Ku70-/- 
cells. Data for Ku70-/- was obtained from (5). B) Fraction of repair corresponding to MHD and 
TINS averaged across the 5 break sites tested in cells expressing POLQ (orange) or not 
(black). The fold difference is shown and was calculated as the fraction in POLQ expressing 
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cells divided by the fraction in parental POLQ-/- cells. C) The frequency of TINS/tumor 
genome was determined for tumors with high or low levels of POLQ expression determined 
as in Fig. 2.10A, except tumors with germline BRCA mutations were excluded. D) Average 
percent AT content in TINS found in tumor genomes defined as in Fig. 6 (blue), compared to 
the average AT content in the 100 bp surrounding the insert (Flanks, white). Statistical 
significance was assessed by a two-tailed t-test; *, p<0.05. E) Levels of POLQ mRNA were 
normalized as in Fig. 2.10A, and compared in tumors with wild type (wt) germline BRCA 
genes vs. tumors with germline mutations in BRCA genes. Statistical significance was 
assessed with a two-tailed Mann-Whitney test, *p<0.05. 
 
 
Figure 2.10. TINS are increased in 
tumors with high POLQ expression 
and with BRCA mutations. A) and B) 
Number of insertions with templated 
synthesis 5 bp or more per tumor 
(TINS/tumor, defined as in figure 4A) for 
breast cancer genomes previously 
sequenced by ICGC were determined 
according to differing POLQ mRNA 
expression level (A) or BRCA1 or BRCA2 
germline status (B). A) POLQ expression 
in fragments per kilobase of transcript per 
million was normalized based on HPRT1, 
TBT and GAPDH expression for 261 
breast cancers. Tumors were categorized 
as expressing low (POLQ Low; bottom 
quartile) or high levels of POLQ mRNA 
(POLQ High; top quartile). Statistical 
significance was assessed with a two-
tailed Mann-Whitney test; *, p<0.05. B) 
Breast cancers were categorized as 
having germline BRCA1 or BRCA2 




Pol θ is required for viability in cancer cell lines deficient in BRCA1/2 (Ceccaldi et al. 
2015; Mateos-Gomez et al. 2015), and higher levels of POLQ expression are observed in 
BRCA1/2 mutated breast cancers (Fig. 2.7E) (Higgins et al. 2010; Lemée et al. 2010; Ceccaldi 
et al. 2015). We show here that the genomes from the 75 breast cancer patients with germline 
BRCA mutations had a median of 7 TINS/genome, a much higher frequency than that observed 
in the remaining patients with no germline BRCA mutations (2 TINS/genome) (p<0.0001, Mann-
Whitney test) (Fig. 2.10B). The ability to correlate BRCA1/2 deficiency with increased frequency 
of TINS, a biomarker more directly reflective of Pol θ/TMEJ activity than expression, provides 
further support that addiction to TMEJ is broadly associated with BRCA1/2 deficient cancers.  
Discussion  
Mechanistic basis for microhomology identification 
TMEJ identifies microhomologies through a scanning mechanism that is initiated from 
the 3’ terminus, and favors break-proximal, 2 bp or larger microhomologies (Fig. 2.3B). 
Increased size of microhomology can modestly extend the distance searched beyond the 15 bp 
limit described above (Fig. 2.3A), and also impacts the extent proximal microhomologies are 
favored. Asymmetrically located pairs of microhomologies are used less efficiently than a 
symmetrically located pair of microhomologies (e.g., 10/10 vs. 2/15 substrates, Fig. 2.3A; 2.4A, 
or Fig. 2.1F), implying scanning is typically bi-directional.  
Past work from our group and others has determined that in some contexts, Pol θ-
dependent repair can include microhomologies more distal than 15 bp from 3’ termini. These 
contexts include cells deficient in regulation of end resection (cells defective in KU70 or 53BP1) 
or wild type cells after a much longer recovery period than is used here (24 hours) (Wyatt et al. 
2016; Schimmel et al. 2017; Feng et al. 2019). Given similar results using pre-resected 
extrachromosomal substrates (where we can systematically vary microhomology availability 
relative to a definitive 3’ ssDNA terminus), we suggest this second class of Pol θ-dependent 
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products reflects loss of 3’ terminal ssDNA before Pol θ could be engaged, rather than a 
fundamental change in the preference of Pol θ for break proximal microhomologies.  Loss of 3’ 
ssDNA after resection can be inferred by substitution of long tracts of flanking target DNA with 
donor-specific sequence in the majority of gene-targeting products (e.g., (Kan et al. 2017)), and 
can be also observed when using pre-resected extrachromosomal substrates (Wyatt et al. 
2016). Possible mechanisms for loss of 3’ ssDNA termini include engagement of the Artemis 
endonuclease in the context of canonical NHEJ (Shibata et al. 2017), or engagement of Pol δ 
editing exonuclease activity in the context of homologous recombination (Anand et al. 2017; 
Kan et al. 2017).  
Moreover, there is little mechanistic rationale for use of microhomologies >15 bp from 
either side of the break site, since i) for break sites rich in microhomologies in this region, the 
identification of these microhomologies is both efficient (Fig. 2.1F) and strongly favors the most 
break-proximal microhomologies (Fig. 2.3B), and ii) for the 7% of break sites without a break-
proximal microhomology 3 bp or more (Fig. 2.1B), iterative rounds of synthesis can generate 
microhomologies de novo that are now longer, and which support processive synthesis and 
successful repair (Fig. 2.6).  
Mechanism of template-dependent insertions 
Repair by simple Pol θ-dependent MHD is unlikely to be efficient at the 7% of break sites 
that do not have microhomologies 3 bp or more within 15 nt of the break site, and instead 
generates near-compensatory levels of Pol θ-dependent products with locally templated 
insertions (TINS; Fig. 2.6A). We show that both classes of Pol θ mediated repair – MHD and 
TINS – are products of synthesis initiated from primers annealed to template at sites of short 
complementary sequence. TINS reflect instances of alignment and synthesis where synthesis 
was not sufficiently processive to allow for complete repair. Such failures are primarily due to 
alignments that rely on short, <3 bp microhomologies or no microhomology, consistent with in 
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vitro data emphasizing the importance of alignments of larger microhomologies for processive 
synthesis (He and Yang 2018; Black et al. 2019). However, failure is also more frequent if 
synthesis proceeds through AT-rich regions (Fig. 2.6D, Fig. 2.8), implying a contribution of 
ongoing synthesis to the stabilization of the aligned ends. Importantly, the initial aborted round 
of synthesis often generates a new, larger microhomology (Fig. 2.6F). This explains how TINS 
is compensatory in microhomology-poor, AT-rich regions – it is effectively an adaptive 
mechanism, as Pol θ can generate new microhomologies that are sufficiently stable to sustain 
processive synthesis and successful repair. 
We show that TINS is a specific marker for TMEJ activity (Fig. 2.9B). They are present 
at a much higher frequency in a panel of 75 breast cancers with germline mutations in BRCA1/2 
(Fig. 2.10B), consistent with a requirement for TMEJ for viability of several BRCA1/2 defective 
cancer cell lines (Ceccaldi et al. 2015; Mateos-Gomez et al. 2015). Indeed, Pol θ is required for 
viability in the context of a wide variety of DNA damage response defects, and thus is as an 
attractive target for therapy in as many as 30% of all breast tumors (Higgins and Boulton 2018; 
Feng et al. 2019). Assessment of TINS in tumor genomes thus holds promise as a biomarker for 
deciding when TMEJ should be targeted for cancer therapy.  
Relationship of TMEJ to other end-joining repair  
We have defined the outcomes of TMEJ as i) those deletion products associated with 
microhomologies 2 bp or more that are located within 15 bp of either side of the break site, as 
well as ii) products with 5 bp or more of synthesis that results in an insertion, and the synthesis 
employs template within 50 bp of either side of the break site.  
Loss of Pol θ does not typically lead to compensatory increases in the accurate, <5 bp 
deletion products that can be clearly linked to NHEJ (Fig. 2.11A) (Schimmel et al. 2017). 
Instead, repair is re-channeled to “other” products with larger deletions (>15 bp from either side 
of the break site; Fig. 2.11A) that also favor microhomologies, though to a lesser degree than 
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TMEJ (Fig. 2.11B). The contribution of TMEJ to overall repair also varies little over the 5 break 
sites tested – an average of 8.4+/-1.5% (standard deviation) – despite wide variation in the 
availability of microhomologies. Taken together, our results imply 5-10% of Cas9-induced DSBs 
preferentially engage TMEJ and not NHEJ, likely because these DSB ends have been resected 
(Fig. 7C). As also noted above, less accurate end joining products that are enriched in Pol θ 
deficient cells may at least in part reflect clipping of 3’ ssDNA tails generated by resection (e.g., 
by Artemis) (Wyatt et al. 2016; Shibata et al. 2017), followed by NHEJ or yet-undefined alternate 
end joining mechanisms. 
A role for microhomologies in mammalian end joining has long been clear (Roth and 
Wilson 1986). Our work shows they have a variety of sources. Some microhomology associated 
deletions (MHD) are generated by both Pol θ/TMEJ and NHEJ (those with less than 5 bp of 
deletion; Fig. 2.9A), while others are primarily attributable to Pol θ/TMEJ (between 5-15 distal to 
either flank; Fig. 2.1F). Yet a third class (those suppressed by TMEJ in otherwise wild type cells, 
and more than 15 bp from either strand-break terminus; Other, Fig. 2.11A) has distinct and 
probably complex genetic requirements. MHD are thus generated by at least three genetically 
distinguishable mechanisms, highlighting a critical flaw in the frequent attribution of such 
products to a single microhomology mediated end joining pathway (“MMEJ”) (Fig. 2.11C). 
Implicit to a requirement for microhomologies during end-joining is i) an associated loss 
of genomic information, and ii) potentially impaired repair in contexts where microhomologies 
are hard to find. We describe here how an elegant search mechanism largely overcomes these 
limitations in a manner that in most contexts – e.g., in cells proficient in canonical pathways, and 
which appropriately regulate end resection – least threatens genome stability. At the same time, 
cancer-causing deficiencies in BRCA genes leads to excessive engagement of TMEJ and 




Figure 2.11. TMEJ promotes genomic 
stability. A) The extent of enrichment of 
repair product classes 1 upon POLQ 
expression, averaged across all 5 break 
sites. Products were classified as NHEJ 
(white 2 bar) if deleted sequence was less 
than 5 bp and possessed no or 1 bp of 
microhomology, as TMEJ 3 (orange bar) if 
deleted sequence was less than 15 from 
either end and possessed 2 bp or more of 
4 microhomology, or had templated 
insertions larger than 2 bp, and as “other” 
(black bar) if deleted 5 sequence from 
either flank exceed 15 bp. Bar represents 
the mean and error bars SEM from 3 6 
biological replicates. B) Average fraction 
of repair events associated with the 
indicated 7 microhomology sizes in 
deletions larger than 15 bp from both 
sides of the break (other) or as would 8 be 
expected by chance, if microhomologies 
played no role (expected). C) Following a 
double strand 9 break (DSB), ends are 
either ligated through the NHEJ pathway 
(dependent on the KU 10 heterodimer) or 
resected to form 3’ ssDNA tails. These are 
substrates for TMEJ (dependent on Pol 11 
θ), HR, or a third, undescribed form of end 
joining that also favors microhomologies. 
Different end-12 joining pathways have 
different mutational outcomes (MHD of the 




CHAPTER 3: REQUIREMENTS FOR CELLULAR POLYMERASE THETA-MEDIATED END 
JOINING 
 
“Bien están los buenos pensamientos. Pero resultan tan livianos como burbujas de jabón si no 
los sigue el esfuerzo para concretarlos en acción.” 
 
(Good thoughts are good. But they are as light as soap bubbles if they are not followed by an 
effort to put them into action.) 
 
−Gaspar Melchor de Jovellanos 
Introduction 
Chromosome double strand breaks (DSBs) are a threat to the stability of the genome. 
They occur when both strands of the DNA are broken due to, for instance, problems during 
replication or transcription, or exposure to mutagenic agents. DSBs are also critical 
intermediates during meiosis, the generation of the adaptive immune response, and genome 
engineering. Cells use different repair pathways for the repair of DSBs depending on the 
structure of the break, and the phase of cell cycle they are in (Chapman et al. 2012; Scully et al. 
2019). 
Two pathways are responsible for repairing most DSBs: non-homologous end joining 
(NHEJ) and homologous recombination (HR). During NHEJ, the DNA ends are recognized by 
the Ku heterodimer, made suitable for ligation by end-processing enzymes (e.g., nucleases, 
polymerases), and finally ligated by DNA ligase 4 (Waters et al. 2014b). Alternatively, HR 
begins by the generation of long 3’ ssDNA tails through 5’-to-3’ end-resection; the resected 
ends are used to invade another DNA molecule, ideally identical to the broken one, which is 
used as a template for repair. HR is a complex, multi-stage process that involves the tumor 
suppressors BRCA1 and BRCA2, among many other proteins (Prakash et al. 2015). 
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There are other pathways that cells use to repair chromosome breaks. For instance, end 
joining can be observed in the absence of NHEJ; this has been broadly referred to as alternative 
end joining (a-EJ or alt-NHEJ) (Boulton and Jackson 1996; Kabotyanski et al. 1998; Feldmann 
et al. 2000). a-EJ creates deletions >5bp as well as insertions, and shows a predisposition for 
microhomologies at the deletion junction. For this reason, it is sometimes referred to as 
microhomology-mediated end joining, even if NHEJ also favors microhomology deletions (Roth 
and Wilson 1986; Pannunzio et al. 2014; Carvajal-Garcia et al. 2020a). 
Within the last 10 years it has been shown that in most eukaryotes (all except for fungi), 
the majority of a-EJ products depend on DNA polymerase theta (Pol θ, gene name POLQ), 
constituting a third repair pathway. This chromosome break repaired pathway has been termed 
polymerase theta-mediated end joining (TMEJ) (Chan et al. 2010; Roerink et al. 2014; 
Yousefzadeh et al. 2014). TMEJ, like HR, begins with long 3’ ssDNA tails; within those tails, two 
short (2-6 nt), complementary, sequences are found and annealed, and they serve as primer for 
synthesis by Pol θ, which repairs the break (Wyatt et al. 2016). TMEJ is rarely used in wild type 
cells, yet it becomes essential in certain pathogenic conditions, such as cancer-causing loss of 
proteins involved in HR (BRCA1, BRCA2) (Lemée et al. 2010). For this reason, Pol θ is 
regarded as an encouraging therapeutic target in the treatment of cancer (Higgins and Boulton 
2018). 
Several key mechanistic questions regarding how Pol θ repairs chromosome breaks are 
still outstanding. The exact nature of its starting substrate remains unknown, as Pol θ has been 
proposed to act immediately following end-resection, as well as on more downstream HR 
intermediates (Chan et al. 2010; Ceccaldi et al. 2015; Mateos-Gomez et al. 2015; Wyatt et al. 
2016; Feng et al. 2019; Carvajal-Garcia et al. 2021). In addition, Pol θ has been suggested to 
be involved in the repair of stalled or collapsed replication forks, which may require the use of 
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starting substrates different from the ones described (Koole et al. 2014; Roerink et al. 2014; 
Ceccaldi et al. 2015; van Schendel et al. 2016; Wang et al. 2019). 
On top of our lack of understanding of Pol θ’s biologically relevant DNA substrates, 
these are likely not comprised of naked DNA. Cells contain single stranded DNA binding 
proteins that may represent a potential block for repair by Pol θ. For example, proteins involved 
in the initiation of HR (RPA, RAD51) could bind the resected ends before Pol θ, preventing 
mutagenic repair. Other possible blocks are DNA-protein adducts, which may have caused the 
chromosome break and could still be bound to the DNA. 
Once the microhomology is found and annealed, some end-trimming is likely going to be 
necessary for this microhomology to prime synthesis, as any 3’ non-homologous tails would 
need to be removed; this step of TMEJ remains uncharacterized. Finally, while a good body of 
in vitro work exists regarding DNA synthesis by Pol θ (Arana et al. 2008; Kent et al. 2015; Black 
et al. 2019), very little information is known about how this polymerase behaves in vivo. 
Here, we systematically characterized the substrate specificity of cellular TMEJ using 
extrachromosomal substrates. We describe the length requirements of the ssDNA tails that serve 
as a starting substrate, Pol θ’s activity on a replication intermediate substrate, and its behavior 
with biologically relevant substrates made of DNA-protein complexes. Moreover, we provide 
characterization of the nuclease step of TMEJ, which we find is likely performed by an 
exonuclease. Finally, we show that TMEJ is long patch repair pathway that involves DNA 
synthesis through downstream dsDNA, displacing the complementary strand. These detailed 
mechanistic insights allow us to better understand Pol θ’s role in the cell, its relationship with other 
chromosome break repair pathways, and the possible mutagenic consequences of its use. 
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Materials and Methods 
Cell culture 
Mouse embryonic fibroblasts (MEFs) were obtained from Polq-/- mice from Jackson 
Laboratories that had been maintained on a C57BL/6J background, and immortalized by T 
antigen transformation (Yousefzadeh et al. 2014). To generate the complemented cell line, 
MEFs were infected with a lentivirus containing the cDNA of human POLQ (Yousefzadeh et al. 
2014). MEFs from Ku70-/- and p53-/- mice were transduced with an empty vector retrovirus, or 
with mouse Ku70 cDNA (Yousefzadeh et al. 2014). 
Cells were maintained at 37 °C, 5% CO2 and cultured in DMEM (Gibco) with 10% Fetal 
Bovine Serum (VWR Life Science Seradigm), Penicillin (5 U/ml, Sigma), and 4 μg/ml of 
puromycin when appropriate. All cell lines were confirmed to be free of mycoplasma 
contamination by a qPCR (Janetzko et al. 2014). Cell lines were randomly selected for third 
party validation of qPCR results by Hoechst staining (Battaglia et al. 1994). 
Extrachromosomal substrate generation 
“Pre-resected” extrachromosomal substrates consisted of oligonucleotide duplex caps 
(oligonucleotide sequences in table S1) ligated to a 557 bp double stranded core made by PCR 
amplification to generated DNA fragments with the noted end structures. Excess caps was 
removed with the QIAquick PCR Purification Kit (QIAGEN), and complete substrate assembly 
and removal of excess tails was confirmed by gel electrophoresis 
Extrachromosomal assay 
75 ng of  the substrates described above were electroporated into 200,000 cells with 1 
ug of pMAX-GFP (Lonza) using the Neon system (Invitrogen) in a 10 ul tip with a 1,350 V, 30 
ms pulse (three pooled electroporations formed one biological replicate) and incubated for 1 h. 
For figures 2c and 3, 20 pmol of streptavidin (NEB), the indicated amounts of purified human 
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RPA (a gift from Dr. Aziz Sancar), or 5 pmol of Escherichia coli SSB (Thermo) were included in 
the electroporation mix and incubated with the substrate for 10 mins on ice. Cells were washed 
with Hank’s balanced saline solution, incubated with 25U of Benzonase (Sigma) with 5 mM 
MgCl2, and DNA was purified using the QIAamp DNA mini kit (QIAGEN). Products were 
analyzed using SYBR green qPCR (Applied Biosystems) using the ∆∆Ct method or a 26-cycle 
end point PCR using Phusion® High-Fidelity DNA Polymerase (NEB) (primer sequences in 
table S2). Each experiment consisted of three replicates of the above protocol. Quantification of 
gel bands was done with ImageQuant 8.1. For figure 5, DNA was incubated for 1 h at 37 °C with 
Phusion® HF buffer (NEB) and BamHI (NEB) when indicated previous to amplification by end-
point PCR. 
For fig 3d and fig S3b, the assay was performed with 37.5 ng of substrate and without 
pMAX-GFP, due to RAD51’s ability to bind dsDNA. For RAD51 binding, the indicated amount of 
protein was incubated in 100 mM NaCl, 2 mM ATP, 0.05% Triton-X, as well as 2 mM CaCl2 for 
10 minutes at 37 °C. These conditions allow RAD51 to bind DNA and not be released (Bugreev 
and Mazin 2004). After electroporation, cells were incubated for 30 mins, and the experiment 
was completed as indicated above for all other substrates. 
RAD51 purification 
The purification of hRAD51 was performed as previously described in (Sigurdsson et al. 
2001) with the following change. The clarified lysate was incubated with 1 mL of nickel NTA 
Sepharose (GE Healthcare), and bound protein was eluted with 10 mL of Buffer B (20 mM 
KH2PO4 pH 7.4, 10% glycerol, 1 mM EDTA, 1 mM DTT) containing 500 mM imidazole and 150 
mM KCl. The eluate was pooled and fractionated using a Macro-hydroxyapatite column 
(BioRad), MonoS and MonoQ columns (GE Healthcare) as described in (Sigurdsson et al. 




For figures 4 b and d, DNA from three biological replicate experiments was pooled and 
amplified for 22 cycles with primers purified by polyacrylamide gel electrophoresis (IDT) that 
included 21 (fwd primer) or 22 (rev primer) bp of Illumina adapter sequence (primer sequence in 
table S2). Excess primer was cleaned with the QIAquick PCR Purification Kit (QIAGEN) and 
DNA was amplified for 5 extra cycles with primers that included all of the Illumina adaptor 
sequence. DNA was then cleaned using AMPure XP beads (Beckman Coulter). Libraries were 
sequenced using a 300-cycle iSeq 100 i1 Kit (Illumina). Amplicons from an experiment that is 
not part of this manuscript provided the necessary sequence diversity. Data was analyzed using 
CLC Genomics Workbench 8 and Microsoft Excel. 
EMSAs 
For the electrophoretic mobility shift assays (EMSAs) in figures S2B, S3A, and S3C, 
substrates were generated as described above, but using a Cy5 labeled oligo. 75 ng of 
substrate were incubated with the indicated amounts of streptavidin, RPA and SSB for 10 mins 
on ice, electroporated as described above, and run cold in a 5% polyacrylamide for 45 min at 
150V. 
For figure S3D, 36 ng of Cy5-labeled substrate were incubated with 100 mM NaCl, 2 mM 
ATP, 0.05% Triton-X, as well as 2 mM CaCl2 for 10 minutes at 37 °C, and run cold in a 5% 
polyacrylamide for 45 min at 150V. 
Results 
ssDNA length requirement for TMEJ 
The starting substrate for TMEJ is generated following end-resection, the 5’-to-3’ 
degradation of both double strand break ends. Pol θ is then able to join these resected ends, 
serving as an alternative to HR during the repair of chromosome breaks. End-resection consists 
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of two phases: first, a short stretch of 3’ ssDNA is generated by MRE11, which couples an 
endonucleolytic nick and 3’-to-5’ exonucleolytic degradation. Second, further 5’-to-3’ ssDNA 
degradation is achieved by two distinct end-resection machineries, one with EXO1 and the other 
with DNA2 acting as nucleases (Lee et al. 1998; Gravel et al. 2008; Mimitou and Symington 
2008; Nimonkar et al. 2008; Zhu et al. 2008). In the end, end-resection can create 3’ ssDNA 
tails that are hundreds of nucleotides long in mammalian cells (Zhou et al. 2014; Symington 
2016). Both stages of resection could conceivably create a substrate for TMEJ. However, it 
remains unclear which lengths of 3’ ssDNA are amenable substrates for Pol θ, and therefore 
can be joined by TMEJ.  
We decided to systematically test the ssDNA length requirements for TMEJ with the use 
of “pre-resected”, extrachromosomal, DNA substrates, with between 10 and 70 nt of ssDNA. We 
have previously shown that when we introduce these substrates into mammalian cells, two 
classes of end-joining products are generated. One utilizes a microhomology and retains the 
overhangs, while the other clips them and joins the resulting blunt DNA ends (Fig 3.1A), and 
these two products are easily discernible by PCR followed by gel electrophoresis (Fig 3.1B) 
(Wyatt et al. 2016).  
We transfected the extrachromosomal substrates with varying ssDNA (10-70 nt), and an 
equivalent, 4 nt, terminal microhomology into Polq-/- MEFs complemented with human POLQ 
and the isogenic Polq-/- cells (Yousefzadeh et al. 2014). We observed that all overhang-retaining 
products solely depend on Pol θ with the exception of the substrate with 10 nt of ssDNA (Fig 
3.1B). Also, we observed that the longer the 3’ overhang, the less frequently the overhang-
cleaving product was formed, which can be explained by its dependence on the Ku heterodimer, 
as the efficiency of loading of Ku is lower for ssDNA than it is for dsDNA (Foster et al. 2011; 
Wyatt et al. 2016). Interestingly, the length requirement observed is consistent with the DNA 
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structures generated by MRE11-dependent resection, further supporting the idea that TMEJ 
occurs downstream of this class of end-resection.  
 
Figure 3.1. ssDNA length requirement for TMEJ. A) Schematic of the extrachromosomal 
substrate assay. Linear fragments of DNA with increasing lengths of 3’ ssDNA (from 10 to 
176 nt) were introduced in Polq-/- MEFs complemented with human POLQ cDNA or not. 
Repair products were harvested and analyzed by end-point PCR and PAGE (B) or qPCR (C). 
B) Three biological replicates of Polq-/- cells with or without human POLQ expression, 
transfected with extrachromosomal substrates with the indicated lengths of 3’ ssDNA, were 
pooled and amplified by end-point PCR with primers that detect overhang-retaining product 
(top bands) and overhang-clipping products (bottom bands) and run on a 6% PAGE gel. C) 
qPCR that detects only the overhang-retaining product of repair events from substrates with 
70 or 176 nt of 3’ ssDNA in Polq-/- and Polq-/- + POLQ. qPCR results were normalized to the 
joining efficiency observed using the 70 nt substrate. Bars represent the mean and error bars 
the standard error of the mean (SEM), n=3 biological replicates. Statistical significance was 
determined by two-tailed t-test; *, p<0.05. 
 
We then tested whether Pol θ could utilize substrates with longer ssDNA tails. We 
transfected cells with substrates containing 70 nt or 180 nt of ssDNA, and determined the 
efficiency of TMEJ by a qPCR that specifically detects the overhang-retaining product. We 
observed Pol θ-depending DNA joining for the 180 nt substrate, which showed a lower 
efficiency than the 70 nt one (Fig 3.1C, Fig 3.2A,B). This implies that TMEJ involves synthesis 
of at least 180 nt, more than most DNA polymerases-dependent processes in the cell, and could 
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be explained by its high processivity observed in vitro (Arana et al. 2008), or by a proposed 
polymerase switch between Pol θ and Pol δ (Kamp et al. 2020). 
 
Figure 3.2. TMEJ using a long substrate has reduced efficiency. A) A qPCR of two 
standards mimicking the microhomology mediated, overhand retaining, TMEJ products 
of the substrates with 70 nt and 176 nt of 3’ ssDNA. The points correspond to 5,000, 
10,000, 50,000, and 100,000 molecules of initial template per qPCR reaction. The 
slope with its 95% confidence interval and the R2 are indicated. B) The samples used 
for Fig. 1C for cells expressing POLQ were amplified by end-point PCR to detect the 
overhang-containing products. 
 
TMEJ requires two free DNA ends, one of them single stranded 
Generally, DNA end resection produces two free, single stranded, DNA tails that are 
mostly symmetric. However, other end structures may be amenable to Pol θ-dependent repair. 
This is the case for one-ended double strand breaks, where only one of the ends is single 
stranded while the other remains double stranded, that are generated at stalled replication forks. 
We designed extrachromosomal substrates that mimicked these types of asymmetric 
breaks — one end has 70 nt of 3’ ssDNA tail, while the other is blunt (ss-ds substrate) — and 
compared it to the symmetric substrate with two 70 nt ssDNA ends (ss-ss substrate) (Fig. 3.3A). 
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We placed a 4 bp microhomology in both ends, that was two nucleotides embedded into the 
ssDNA end, and either terminal (ss-ds0) or 2 bp embedded into the dsDNA end (ss-ds2).  
 
Figure 3.3. TMEJ can join 
replication fork-like structures. 
TMEJ substrates had either 70 nt of 
ssDNA on each side (ss-ss), 70 nt of 
ssDNA one side and a blunt end on 
the other (ss-ds0 and ss-ds2), or 70 
nt of ssDNA one side and 6 bp of 
unpaired ssDNA sequences on the 
other. A 4 nt microhomology was 
placed 2 nt embedded into the 
ssDNA sides and either terminal (ss-
ds0) or 2 nt/bp embedded (s-ds2 and 
ss-dsF) on the blunt/forked sides. B) 
and C) The indicated substrates 
were transfected into Polq-/- + POLQ 
or Polq-/- (B), or Ku70-/- + Ku70 or 
Ku70-/- (C). Joining efficiency for the 
overhang-retaining products was 
determined by qPCR and normalized 
to the one of the ss-ss substrate 
transfected into the complemented 
cell lines. Bars represents the mean 
and error bars the SEM from 3 
biological replicates. Statistical 
significance was assessed by one-
way ANOVA with Bonferroni 
correction to account for multiple 
comparisons (B) or by two-tailed t-
test (C); NS, not significant; *, 
p<0.05. 
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We introduced the substrates in figure 3.3A into MEFs with or without expression of 
human POLQ as described above, and used the qPCR specific for the overhang-retaining 
product to quantify the joining efficiency. We observed Pol θ dependent repair of the ss-ds 
substrate, with roughly 50% of the efficiency of the ss-ss substrate, regardless of the position of 
the microhomology in the double stranded part if the substrate (Fig. 3.3B). Unpairing the 
sequence that contains the microhomology, forming a small fork (ss-dsF substrate) partially 
rescues the loss of joining efficiency, suggesting that this loss is due to inefficient use a paired 
microhomology (Fig 3.3B). End-point PCR and product characterization by PAGE confirmed 
that the tail-retaining and the tail clipping products are formed with this substrate (Fig. 3.4). 
Due to these substrates having a blunt double stranded end, we reasoned that the Ku 
heterodimer may be recognizing this substrate and joining it independently of Pol θ to generated 
a head-to-heat repair product not detected by our qPCR. This would explain the loss of TMEJ 
joining efficiency when comparing the ss-ds substrates with the ss-ss substrates. We therefore 
transfected the ss-ss and the ss-ds0 substrates into Ku70-/- cells complemented with either wt 
mouse Ku70 cDNA, or an empty vector. Surprisingly we observed that the overhang-retaining 
product is also dependent on KU70 (Fig. 3.3C, Fig. 3.4). As previously described, KU70 has no 
effect in joining the ss-ss substrate (Fig. 3.3B) (Yousefzadeh et al. 2014).  
 
Figure 3.4. Repair products of 
replication fork-like 
substrates. The indicated 
samples from Fig. 3.3B and 
3.3C were amplified by end-
point PCR to detect the 
overhang- retaining and the 
overhang-clipping products and 
run in a 6% PAGE. 
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Another type of DNA end structure that can be formed after resection includes a 
covalently linked protein at the 3’ end. This type of damage is generated, for instance, when 
class 1 topoisomerases are trapped in the DNA after the formation of the Top1 cleavage 
complex (Top1cc) by drugs such as camptothecin (Pommier et al. 1996). We created a DNA 
substrate that resembles the Top1cc by adding a molecule of biotin to either one or both 3’ 
ends, of the pre-resected substrate and incubating it with an excess of streptavidin before 
introducing it into cells (Fig. 3.5). Streptavidin tightly binds the biotin molecule even after 
electroporation as shown by an electrophoretic mobility shift assay (Fig. 3.6). 
 
Figure 3.5: TMEJ requires 2 free 3’ ends. Extrachromosomal substrates with 45 nt of 3’ 
ssDNA tails, a 4 nt microhomology embedded 2 nt, and with or without a biotin molecule 
with a triethylene glycol linker on the indicated terminus were incubated with 20 pmol of 
streptavidin when indicated and transfected into Polq-/- + POLQ or Polq-/- MEFs. Joining 
efficiency for the overhang-retaining products was determined by qPCR and normalized to 
the one of the substrate without biotin or streptavidin. The experiment with the 5’ biotin was 
performed independently. Bars represents the mean and error bars the SEM from 3 
biological replicates. Statistical significance was assessed by one-way ANOVA with 
Bonferroni correction to account for multiple comparison; NS, not significant; *, p<0.05. 
 
A biotin at one or both 3’ ends alone had no influence in the efficiency of TMEJ, while 
one streptavidin-blocked 3’end was enough to completely block repair, showing that Pol θ 
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requires two free 3’ ends for efficient TMEJ (Fig 3). This was also the case when both ends 
were blocked (Fig 3.5). As previously shown, placing the biotin in the 5’ terminus had no effect 
on TMEJ efficiency (Fig 3.5) (Wyatt et al. 2016). 
 
Figure 3.6. Electrophoretic mobility 
shift assay of biotin-containing 
substrates. The indicated substrates, 
like the ones from figure 3.5 but 
including a Cy5 label, were incubated 
with 20 pmol of streptavidin, 
electroporated (without including cells in 
the tip) and run as described in the 
methods. 
 
These results show that Pol θ requires two free 3’ DNA ends, one of them single stranded, 
to join a chromosome break.  
RPA and RAD51 specifically inhibits TMEJ 
Following end-resection, replication protein A (RPA) tightly binds the newly formed 
ssDNA, with one RPA trimer for every 30 nt of ssDNA (Blackwell and Borowiec 1994). RPA 
could represent a barrier to the microhomology search and synthesis steps of TMEJ, and has 
been shown to inhibit DNA synthesis by the polymerase domain of Pol θ in vitro as well as to 
inhibit Pol θ-mediated chromosome fusions (Mateos-Gomez et al. 2017). We tested whether we 
observed inhibition by RPA in vivo in our system, by incubating a TMEJ substrate with 45 nt of 




Figure 3.7. TMEJ is specifically inhibited by RPA and RAD51. A) Extrachromosomal 
substrates with 45 nt of 3’ ssDNA tails and a terminal, 4 bp, microhomology were incubated 
with the indicated amounts of purified human RPA, 5 pmol of Escherichia coli SSB, or the 
indicated amount of purified RAD51. RPA binds ssDNA and RAD51 binds both ssDNA and 
dsDNA. RAD51 was incubated in the presence of 2 mM ATP and 2 mM Ca2+ to allow for 
binding but not release. B) Substrates incubated with the indicated relative amounts of RPA, 
assuming one RPA complex binds to 30 nt of ssDNA, were transfect into Polq-/- + POLQ (blue 
dots) or Polq-/- (white dots) MEFs. Joining efficiency for the overhang-retaining products was 
determined by qPCR and normalized to the one of the substrate without RPA. C) Substrates 
incubated with no proteins, 7 pmol of RPA, or 5 pmol of SSB were transfected into Polq-/- + 
POLQ MEFs, and joining efficiency was calculated and normalized as in B. D) Substrates 
incubated with the indicated relative amounts of RAD51, assuming one RAD51 complex binds 
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to 3 nt of ssDNA or 3 bp of dsDNA, were transfect into Polq-/- + POLQ (blue dots) or Polq-/- 
(white dots) MEFs. Joining efficiency was calculated and normalized as in B. Dots and bars 
represent the mean and error bars the SEM, n = 3 biological replicates. Statistical significance 
was assessed by one-way ANOVA with Bonferroni correction to account for multiple 
comparison; NS, not significant; *, p<0.05. 
 
We observed a concentration-dependent loss in joining efficiency of the TMEJ substrate, 
with a 50% decrease in efficiency with 2.5 molecules of RPA/30 nt of ssDNA (Fig. 3.6B, Fig 
3.7A), and a 91% reduction for when 40X RPA was added (Fig. 3.6C). Importantly, the joining 
efficiency for the NHEJ-dependent overhang-cleaving product was not inhibited by even high 
concentrations or RPA, showing that inhibition by RPA is specific to TMEJ (Fig 3.7B). 
 Interestingly, we observed no inhibition by pre-binding of the substrate with similar 
amounts of E. coli single stranded binding protein (SSB), a functionally equivalent bacterial 
protein (Fig. 3.6C, Fig 3.6C). These results show that the inhibition of TMEJ by RPA is specific. 
This also suggests that the DNA substrate used by Pol θ for repairing chromosome breaks 
might not be form right after end-resection, but rather a latter-formed HR intermediate. This has 
been suggested to be the case in Drosophila melanogaster and Caenorhabditis elegans (Kamp 
et al. 2020; Carvajal-Garcia et al. 2021). 
To initiate HR, RPA is substituted with RAD51 in the 3’ssDNA tails. RAD51 is a 
recombinase that searches for sequences complementary to the ssDNA it binds in dsDNA, in a 
process known as strand exchange. We tested whether a RAD51 binding effects joining by 
TMEJ by pre-incubating the pre-resected substrate with purified human RAD51 in conditions 
that allow for RAD51 binding but not dissociation (Bugreev and Mazin 2004) (Fig 3.6A). We 
observed a concentration-dependent inhibition of TMEJ by RAD51. Each RAD51 molecule 
binds to 3 nt/bp, so a ≈600 nt/bp substrate is bound by approximately 200 molecules of RAD51. 
A 20X excess of RAD51 molecules than DNA molecules had no effect on joining efficiency 
(98% of a RAD51-free reaction), while incubation with 100 molecules of protein per molecule of 
DNA – or 0.5 molecules of RAD51 per 3 nt/bp of DNA –, decreases joining efficiency to 41%. 
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Finally, a saturating amount of RAD51 (1000X), completely inhibits joining efficiency (Fig 3.6D). 
Similarly to RPA, high concentrations of RAD51 did not reduce the efficiency of overhang 
clipping and joining by NHEJ in Polq-/- cells (Fig 3.7B). 
 
Figure 3.8. The inhibition of TMEJ by RPA and RAD51 is specific. A) The indicated 
relative amounts or RPA (calculated as in Fig. 3.7B) were incubated with a substrate with 45 
nt of 3’ ssDNA labeled with Cy5 and run as described in the methods B) Polq-/- cells were 
electroporated with a substrate with 45 nt of 3’ ssDNA prebound with 7 pmol of RPA or 180 
pmol of RAD51. Joining efficiency was determined by qPCR using primers that detect both 
the overhang-retaining and the overhang-clipping products (the former is missing due to 
absence of POLQ). C) and D) EMSAs performed as in A using 5 pmol of SSB or the indicated 
relative amounts or RAD51 (calculated as in Fig. 3.7D). 
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TMEJ requires exonuclease activity 
TMEJ needs to couple the microhomology search and annealing step with 
microhomology-primed DNA synthesis during chromosome break repair. In the majority of 
cases, the microhomology used will not be immediately adjacent to a 3’ end, so some DNA 
cleavage must occur in order for the annealed microhomology to prime synthesis. At a 
minimum, the phosphodiester bond 3’ of the microhomology needs to be cleaved for such 
microhomology to prime synthesis. This obvious requirement for a nuclease has been proposed 
before, yet no evidence of a nuclease activity during TMEJ has been described.  
We tested this requirement with an extrachromosomal substrate in which the dominantly 
used, 4 nt microhomology was placed 5’ of a string of 5 deoxythymidines (dTs), therefore 
necessitating 3’ DNA end degradation to activate the microhomology for Pol θ-dependent 
joining (fig. 3.9A). We compared the efficiency of joining with the one of a substrate in which we 
substituted the phosphodiester bond 3’ of the microhomology with a phosphorothioate bond, 
which can inhibit the activity of most nucleases in the cell (Fig. 3.9A).  
Surprisingly, we observed that cells could still join the substrate with the 
phosphorothioate bond, approximately half as efficiently as the one with only phosphodiester 
bonds (Fig 3.9A). One straightforward explanation for this result is that the bond immediately 5’ 
of the phosphorothioate could be the one being cleaved, forming a 3 bp microhomology that 
could be used by Pol θ to prime DNA synthesis. We tested this idea by substituting all the bonds 
within the microhomology with phosphorothioates, and saw no further decrease in joining 
efficiency (Fig 3.9A). 
Another possible explanation for the lack of complete inhibition by these two 
phosphorothioate-containing substrates is the stereoisomeric nature of these bonds. During 
chemical synthesis, both stereoisomers — (R) and (S) — are equally likely to be formed, and 
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certain nucleases are only completely inhibited by one of the two forms (Brautigam and Steitz 
1998). 
 
Figure 3.9. The TMEJ nuclease starts cleaving from the 3’ end. A) Substrates with 70 nt 
of 3’ ssDNA and a 4 nt microhomology embedded 5 nt into the 3’ end, with or without 
phosphorothioate bonds, as indicated by the arrows, were transfected into Polq-/- + POLQ or 
Polq-/- MEFs. Joining efficiency for the overhang-retaining products was determined by qPCR 
and normalized to the one of the substrate without phosphorothioate bonds. B) Three 
biological replicates for the indicated substrates were pooled, amplified, and sequenced 
(iSeq, Illumina). The percent of repair events corresponding to the main product, as well as to 
the two products with the largest relative increase in joining in the substrate with 
phosphorothioate bonds are indicated. The number of sequences analyzed were 360 for the 
substrate without phosphorothioate bonds and 323 for the substrate with phosphorothioate 
bonds. C) Substrates with 70 nt of 3’ ssDNA and a 4 nt microhomology embedded 5 nt into 
the 3’ end, with or without phosphorothioate bonds, as indicated by the arrows, were 
transfected into Polq-/- + POLQ (blue dots) or Polq-/- MEFs (white dot). Joining efficiency was 
calculated and normalized as in A. D) Three biological replicates for the indicated substrates 
were pooled, amplified, and sequenced (iSeq, Illumina), the sequences for the 
phosphorothioate-free substrate are the same as in B. The percent of repair events 
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corresponding to the main product, as well as to the product with the largest relative increase 
in joining in the substrate with phosphorothioate bonds are indicated. The number of 
sequences analyzed for the substrate with a phosphorothioate bond is 767. For panels A and 
C, bars and dots represent the mean and error bars the SEM.  
 
We tested whether this was the case, by amplifying the joining products of the 
phosphorothioate-free substrate and the substrate with phosphorothioates in the microhomology 
bonds, and performing high-throughput sequencing (iSeq, Illumina). The 4 bp microhomology 5 
nt away from the 3’ end was the main repair product for both substrates, yet it was reduced for 
the phosphorothioate-containing one (75.7% and 51.7% of repair respectively) (Fig. 3.9B). The 
most increased product in the phosphorothioate-containing substrate with respect to the 
phosphorothioate-free one utilizes a 2 bp microhomology that contains one the Ts placed 3’ of 
the main microhomology (1.11% of repair vs. 8.34%) (Fig. 3.9B) The use of this microhomology 
allows for cleavage of a phosphodiester bond instead of a phosphorothioate. The next most 
increased phosphorothioate-dependent product utilizes the same 4 bp microhomology of the 
main product, but initiates synthesis from a mismatched nucleotide pair (2.22% of repair vs. 
6.19% of repair) (Fig. 3.9B). This type of product also allows for cleavage of a phosphodiester 
bond previous to DNA synthesis. 
The conclusions of this experiment are two-fold: 1) the nuclease required for TMEJ is 
partially inhibited by the presence of a phosphorothioate bond, and 2) this nuclease begins 
cleaving DNA from the 3’ end of the ssDNA tail, and therefore is likely an exonuclease. This is 
because both products increased in the presence of phosphorothioate bonds require the 
cleavage of phosphodiester bonds 3’ of the phosphorothioate bonds, and never 5’. 
To further establish the latter conclusion, we designed substrates with an increasing 
amount of phosphorothioate bonds, starting from the most 3’ bond and moving inwards. As 
expected, more 3’ phosphorothioate bonds resulted in a decrease in the efficiency of joining by 
Pol θ (Fig. 3.9C). 
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When we sequenced the substrate that contains one terminal phosphorothioate bond, 
we found that the most common product was still the one that uses the 4 bp microhomology 5 nt 
away from the 3’ end (51.8% of repair) (Fig 3.9D). Meanwhile, the product most increased by 
the presence of the phosphorothioate uses a two bp microhomology that is at the 3’ terminus of 
one of the ends (2.50% of repair vs. 13.8%), therefore avoiding the cleave of phosphorothioate 
bonds (Fig. 3.9D). These results confirm the two conclusions stated above, regarding the partial 
inhibition of the TMEJ nuclease by the phosphorothioate bonds and the fact that this nuclease is 
likely an exonuclease. 
TMEJ is a long-patch repair pathway 
Once the nucleotides that make the microhomology are annealed, and any 3’ non-
homologous tails are cleaved, this small portion of dsDNA is used to prime DNA synthesis in a 
substrate specific to Pol θ (Kent et al. 2015). This allows Pol θ to fill one the gaps, repairing the 
double strand break. Once the ssDNA gap is filled, Pol θ can fall off at the ss-ds DNA boundary 
(short patch synthesis) or continue synthesis past the dsDNA, displacing the complementary 
strand (long patch synthesis). 
We decided to test if Pol θ can perform strand displacement synthesis in cells. We 
created a TMEJ substrate with 45 nt of 3’ ssDNA that contains a mismatched BamHI site 20 bp 
inside of the dsDNA (Fig 3.10A). If TMEJ involves strand displacing synthesis, it would copy the 
BamHI site, making the substrates sensitive to BamHI digestion. If it does not the site would 
remain mismatched, and the substrate resistant to cleavage by BamHI (Fig 3.10A). As a control, 
we created a similar NHEJ substrate that has 4 nt of 3’ss DNA and is dependent on the X family 
polymerases lambda (Pol λ) and mu (Pol μ), which cannot perform strand displacement 
synthesis (Nick McElhinny and Ramsden 2003; Garcia-Diaz et al. 2004). We observed that 
while the repair products of the NHEJ substrate (Fig 3.10B, lane 1 vs. lane 2) as well as the 
NHEJ products of the TMEJ substrate (Fig. 3.10B lane 5 vs. lane 6, lower bands) are resistant 
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to BamHI cutting, the majority of the TMEJ products are sensitive to BamHI (Fig. 3.10B lane 5 
vs. lane 6, upper bands). When we introduced a TMEJ substrate with a matched BamHI site, we 
observed similar amounts of BamHI sensitivity, indicating that the incomplete BamHI digestion 
is not due to rare instances of non-strand displacement synthesis. 
In addition, we tested whether Pol θ needs a 5’ phosphate in the ss-to-ds transition to 
guide its synthesis [as is the case with Pol λ and Pol μ and has been suggested for Pol θ in vitro 
(García-Díaz et al. 2002; Nick McElhinny and Ramsden 2003; Garcia-Diaz et al. 2004; Kent et 
al. 2015)] by substituting the terminal 5’ phosphate with an abasic site (tetrahydrofuran) (Fig. 
3.10A). As previously reported, the presence of an abasic site in the 5’ end is highly inhibitory in 
the case of the NHEJ substrate (Fig 3.10B, lane 1 vs. lane 3) but has no effect on the joining 
efficiency of Pol θ dependent products (Fig. 3.10B, lane 5 vs. lane 7). This abasic site also has 
no effect on strand displacement (Fig. 3.10B, lane 6 vs. lane 8). 
There is conflicting evidence whether Pol θ can strand displace in vitro (Kent et al. 2015; 
He and Yang 2018). It is important to mention that while repair is dependent on synthesis by Pol 
θ, we have no evidence all the synthesis is Pol θ-dependent, thus another polymerase may be 
responsible for strand displacement.  
Last, we examined how long the strand displacement goes for, by placing the 
mismatched BamHI site 50 bp into the dsDNA (Fig. 3.10C). At that distance the amount of 
BamHI-sensitive products remain very high (80+/-2.6%), yet is significantly lower than when the 
BamHI is placed 20 bp into the dsDNA (93+/-2.2%). 
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Figure 3.10. TMEJ is a long 
patch repair pathway. A) 
Substrates had either 4 nt 
(NHEJ) or 45 nt (TMEJ) of 3’ 
ssDNA, a 4 nt terminal 
microhomology, and a 
mismatched BamHI site 
embedded 20 bp into the dsDNA 
(therefore substrates are initially 
resistant to BamHI cleavage). I 
addition, substrates had either a 
5’ phosphate or a furan in the 5’ 
end. Strand displacement 
synthesis would restore the 
BamHI site, making the repair 
products BamHI sensitive. B) 
The substrates described above 
were introduced into wt MEFs, 
and three biological replicates 
were pooled, digested with 
BamHI when indicated, amplified 
by end-point PCR to detect the 
overhang-retaining and the 
overhang-clipping products, and 
run on a 6% PAGE. C) Fraction 
of strand displacement of TMEJ 
substrates with a mismatched 
BamHI site embedded 20 bp or 
50 bp into the dsDNA was 
determined as in B. A 
representative image of the gel is 
shown. The mean fraction of 
strand displacement was 
determined for three 
independent experiments. Error 
bars denote the SEM. Statistical 
significance was determined by 
two-tailed t-test; *, p<0.05. 
 
Discussion 
TMEJ is an error-prone chromosome break repair pathway in which Pol θ plays a key 
role. TMEJ acts downstream of end resection, and serves as a backup for the two main DSB 
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repair pathways, NHEJ and HR. When compared to these pathways, the molecular mechanism 
of TMEJ remains poorly understood, with questions ranging from the nature of biologically 
relevant substrate(s) to how the break gets resolved. 
Here we characterize a wide range of Pol θ substrates in cells, using an 
extrachromosomal assay that allows us to systematically change the nature of the substrate we 
are providing for Pol θ to join. We show that Pol θ can use symmetric substrates with as little as 
20 bp of ssDNA – in contrast to what has been observed in vitro, where the full length 
polymerase can’t join two 26 nt ssDNA molecules (Black et al. 2019) – and as much as 176 nt, 
possibly more. This wide range of functional lengths may allow Pol θ to act immediately 
following MRN-dependent resection, as it has been proposed to be the case in BRCA1 deficient 
worms (Kamp et al. 2020), but may be less effective after long-range resection. 
We also show that Pol θ can join an asymmetric substrate that mimics a broken 
replication fork, with ssDNA on one end and dsDNA on the other, which can help explain Pol θ’s 
proposed role in the repair of replication-associated damage (Ceccaldi et al. 2015; Feng et al. 
2019; Kelso et al. 2019; Wang et al. 2019). Regarding this substrate, we also find a surprising 
role for Ku. Both Polq and Ku70 deficiencies lead to a 70% reduction in joining efficiency for the 
ss-ds substrate, though our assay is not sensitive enough to distinguish whether Pol θ and Ku 
work collaboratively in the same pathway, or in different pathways that lead to the same 
products.  
Our work shows that TMEJ is a versatile repair pathway. It can utilize substrates of 
different lengths, symmetric or asymmetric, and even overcome an apparent lack of 
microhomologies (Wyatt et al. 2016; Carvajal-Garcia et al. 2020a). This matches its proposed 
role in repairing breaks with anomalous end structures that are poor substrates to NHEJ and HR 
(Wyatt et al. 2016; Feng et al. 2019). However, we have found a substrate that TMEJ can’t join, 
and that is one that has a protein tightly bound to its 3’ end. This substrate mimics a class 1 
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topoisomerase covalently linked to the 3’ end, due to exposure to the drug camptothecin or one 
of its analogs. Interestingly, Pol θ mutants, either by themselves or in combination with 
mutations in HR genes, are hypersensitive to camptothecin (Yousefzadeh et al. 2014; Kelso et 
al. 2019; Carvajal-Garcia et al. 2021). This indicates that Pol θ can repair these types pf breaks, 
but it has to wait for the removal of the trapped enzyme. This result is in accordance with our 
previous finding that the microhomology search process starts from the 3’ end and moves 
inwards (Carvajal-Garcia et al. 2020a), and further suggests that the Pol θ has to thread the 3’ 
ssDNA tails through a channel, possibly located within its helicase-like domain (Newman et al. 
2015). 
TMEJ shares its starting substrate with HR. For this reason, it is not surprising that a 
strong genetic interaction between these two pathways has been described (Chan et al. 2010; 
Ceccaldi et al. 2015; Feng et al. 2019). However, whether Pol θ’s role is purely as a backup 
pathway, or it can directly compete with HR remains an open question (Ceccaldi et al. 2015; 
Mateos-Gomez et al. 2015; Wyatt et al. 2016; Zelensky et al. 2017). Our and others’ work 
suggests that, at least in Drosophila melanogaster, Pol θ cannot compete with the most 
common form of HR, synthesis dependent stand annealing, but it is upstream of a less 
frequently used and more mutagenic form of HR, mitotic crossing over through double Holliday 
junction resolution (Chan et al. 2010; Carvajal-Garcia et al. 2021). This implies that Pol θ’s 
biologically relevant substrate is not generated immediately downstream of end resection, but it 
is an HR intermediate. Accordingly, RPA can suppress Pol θ joining of telomeres (Mateos-
Gomez et al. 2017), and purified Pol θ, while able to inhibit RAD51 filament formation into 
ssDNA, is unable to dissociate them once they’re formed (Ceccaldi et al. 2015). By incubating 
our substrates with purified human RPA and RAD51 previous to electroporation, we were able 
to show a clear inhibition of TMEJ by HR initiating factors. This inhibition was specific to 
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mammalian pro-HR proteins, as the bacterial functional analog of RPA, SSB, did not inhibit 
TMEJ.  
Given the strong inhibition by RPA, it is surprising that we detect any joining at all in our 
experiments, since RPA is much more abundant in cells than Pol θ (http://www.proteinatlas.org) 
(Uhlén et al. 2015)  and has a higher affinity for ssDNA (Yates et al. 2018; Black et al. 2019). 
However, there is a limited amount of RPA in cells, and this protein has been shown to be 
exhausted in the presence of high amounts of ssDNA (Toledo et al. 2014). Therefore, we 
propose that in our assay we’re introducing more DNA molecules that can be bound with the 
existing cellular supply of RPA in cells, and that the molecules that “escape” RPA are the ones 
that Pol θ is able to join. 
The lesser understood step during TMEJ is the nucleolytic step that allows Pol θ to use 
annealed microhomologies as primers for synthesis. This step is required due to the fact that 
any DNA polymerase that utilizes a primer needs an annealed 3’ OH to begin synthesis. To 
understand how this step takes place we took advantage of non-cleavable phosphorothioate 
bonds. Placing multiple phosphorothioate bonds 3’ of a microhomology inhibits its use, while 
putting them 5’ has little effect, indicating that cleavage has to start from the 3’ end and is 
consistent with action of an exonuclease. Interestingly, only one phosphorothioate, either in the 
bond immediately 3’ of a microhomology or in the most 3’ bond of the ssDNA tail only partially 
inhibits TMEJ, and substantially changes the TMEJ product spectra so that the nuclease can 
avoid the phosphorothioate bond. This can be explained by the racemic nature of the of these 
bonds, and the fact that some nucleases are only inhibited by one of the two isoforms. 
The last step during TMEJ is DNA synthesis. It is made possible by one of Pol θ’s most 
striking characteristics, its ability to use very small primers (as small as 1 bp in vitro and possibly 
in cells (Hogg et al. 2012; Carvajal-Garcia et al. 2020a)). One unanswered question about the 
synthesis step during TMEJ is whether when synthesis reaches the dsDNA, the polymerase 
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falls off or keeps synthesizing, displacing the non-template strand. We show that strand 
displacement synthesis happens in substrates specific for TMEJ, in contrast to substrates that 
involve the NHEJ polymerases Pol λ and Pol μ. This strand displacement synthesis can 
continue for at least 50 bp without substantial loss of efficiency. This mechanism helps explain 
how, as shown previously and in this work, modifications in the 5’ end of the ssDNA-to-dsDNA 
transition doesn’t inhibit TMEJ, as continuing synthesis past this point allows the cell to ignore 






CHAPTER 4: DNA POLYMERASE THETA SUPPRESSES MITOTIC CROSSING OVER2 
 
“That's how we're gonna win. Not fighting what we hate, saving what we love.” 
−Rose Tico 
Author summary 
Chromosome breaks are a common threat to the stability of DNA. Mutations in genes 
involved in the early steps of homologous recombination (BRCA1 and BRCA2), a mostly error-
free chromosome break repair pathway, lead to hereditary breast cancer. Cells lacking BRCA1 
and BRCA2 rely on DNA polymerase theta, a key protein for a more error-prone pathway, for 
survival. Using fruit flies and mammalian cells, we have shown that mutations in genes involved 
in later steps of homologous recombination (SLX4 and GEN1) also make cells reliant on 
polymerase theta. Moreover, we have shown that polymerase theta acts upstream of a type of 
homologous recombination that is error-prone and depends on SLX4 and GEN1. This form of 
homologous recombination, termed Holliday junction resolution, creates mitotic crossovers, 
which can lead to loss of heterozygosity and cancer. Our results expand the cellular contexts 
that make cells depend on polymerase theta for survival, and the substrates that this protein can 
use to repair chromosome breaks.  
Introduction 
Double-strand breaks (DSBs) are a particularly toxic form of DNA damage. DSBs are 
generated during common cellular processes (e.g., replication, transcription), after exposure to 
 
2 This chapter is adapted from published work. The original citation is as follows: Carvajal-Garcia J. et al. 
DNA Polymerase Theta Suppresses Mitotic Crossing Over. PLOS Genet. Mar 22;17(3):e1009267. 
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ionizing radiation, or by specialized mechanisms such as meiosis or the development of the 
adaptive immune system (Chapman et al. 2012). DSBs are also essential intermediates during 
nuclease-dependent genome editing. Two pathways account for most DSB repair: non-
homologous end joining (NHEJ), and homologous recombination (HR) (Scully et al. 2019). In 
addition, polymerase theta-mediated end joining (TMEJ) has recently been identified as a third 
DSB repair pathway (Chan et al. 2010; Roerink et al. 2014; Yousefzadeh et al. 2014). 
DNA polymerase theta (Pol θ, gene name POLQ) was first shown to be involved in DSB 
repair in Drosophila melanogaster (fruit fly), and this function was found to be conserved in 
other invertebrates, plants, and mammals (Chan et al. 2010; Yu and McVey 2010; Roerink et al. 
2014; Yousefzadeh et al. 2014; Van Kregten et al. 2016). Inactivation of TMEJ by knocking out 
POLQ orthologs has little to no effect on organismal viability in mice, zebrafish, Drosophila, or 
Caenorhabditis elegans. Only when exposed to exogenous DNA damaging agents does Pol θ 
deficiency negatively impact survival, although to a lesser extent than when other DSB repair 
pathways are compromised (Boyd et al. 1990; Shima et al. 2004; Muzzini et al. 2008; Thyme 
and Schier 2016). However, Pol θ is required in the absence of factors that promote both NHEJ 
(e.g., KU70 and 53BP1) (Wyatt et al. 2016; Feng et al. 2019) and HR (e.g., BRCA1 and 
BRCA2) (Ceccaldi et al. 2015; Mateos-Gomez et al. 2015; Feng et al. 2019), showing that 
TMEJ can compensate for their loss. This is of particular interest in the context of HR-deficient 
breast and ovarian cancer, where Pol θ has been proposed as a promising therapeutic target 
(Higgins and Boulton 2018). 
HR is a multi-stage process that can lead to different repair outcomes, some of which 
can be detrimental (Stark et al. 2004). An important example of detrimental HR is mitotic 
crossing over, as it can result in loss of heterozygosity, which can lead to cancer development 
(Zhu et al. 1992; Luo et al. 2000). The first step in HR is DNA end resection, which generates 3’-
ended ssDNA tails. One tail is used to invade another duplex DNA molecule, forming a 
73 
displacement loop (D-loop) and priming DNA synthesis. Unwinding of the D-loop and 
reannealing to the other end of the broken molecule completes synthesis-dependent strand 
annealing (SDSA). Alternatively, the D-loop may progress to form a joint molecule, the double-
Holliday junction, that needs to be dissolved or resolved through cleavage for the chromosomes 
to be segregated; the latter process can lead to a mitotic crossover (Scully et al. 2019). 
Mechanistically, how Pol θ compensates for the loss of HR proteins is largely unknown. 
Mutations in genes involved in early stages of HR have been shown to be synthetic lethal with 
POLQ mutations. This suggests that when these steps are inactivated, the resulting 3’ ssDNA 
can be used by Pol θ to repair the DSB. It remains unclear whether mutations in genes involved 
in later steps in HR (e.g., downstream of BRCA1/2) can similarly generate recombination 
intermediates that are toxic for cells in the absence of Pol θ activity. 
Here we describe a strong genetic interaction between POLQ and the Holliday junction 
resolvase genes SLX4 and GEN1, which encode some of the latest acting HR proteins, both in 
Drosophila melanogaster and in mammalian cells. We also show that Pol θ suppresses mitotic 
crossing-over in flies, thus protecting cells from this potentially pathogenic form of repair. 
Moreover, our results, together with the observation that POLQ mutations have no effect in 
SDSA in Drosophila (Chan et al. 2010), argue that Pol θ is surprisingly important in processing 
HR intermediates even after D-loop formation. 
Materials and methods 
Drosophila stocks 
Drosophila stocks were kept at 25°C on standard cornmeal media (Archon Scientific). 
Mutant alleles were obtained from the Bloomington Drosophila Stock Center (BDSC) or were a 
gift from Dr. Mitch McVey and have been described in (Klovstad et al. 2008) (Brca2KO), (Thomas 
et al. 2013) (Brca247), (Beagan et al. 2017) (PolQnull) and (Chan et al. 2010) (PolQZ2003), (Yildiz 
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et al. 2002) (mus312D1 and mus312Z1973), (Andersen et al. 2011) (GenZ5997, slx1F93I and 
slx1e01051), and (Trowbridge et al. 2007) (mus81Nhe). PolQnull (a deletion) was used either 
homozygous (Figs 3.1, 3.2 and 3.5), or in trans to PolQZ2003, a nonsense mutation reported to be 
severely hypomorphic (Chan et al. 2010) (Fig 3.6). Brca2 and mus312 alleles were used 
compound heterozygous. GenZ5997 was used hemizygous over the deficiency Df(3L)6103. Since 
mus81 is in the X chromosome, mus81Nhe was used homozygous in females and hemizygous in 
males. Allele-specific PCR was used to detect the presence of the mutant alleles in recombinant 
chromosomes. 
Pictures of fly abdomens shown in figure 4a were taken with a Swiftcam 16 Megapixel 
Camera, and the Swift Imaging 3.0 software.  
Flies expressing Streptococcus pyogenes Cas9 controlled by the nanos promoter, 
inserted on the X chromosome (attPA2) were obtained from BDSC (stock number 54591 (Port 
et al. 2014)). 
Flies expressing a gRNA targeting the rosy (ry) locus (5’-
CATTGTGGCGGAGATCTCGA-3’) were generated by cloning the gRNA sequence into the 
pCFD3 plasmid (Addgene #49410) as in (Port et al. 2014). The gRNA construct was stably 
integrated into an attP landing site at 58A using phi-C31 targeting (stock number 24484) (Best 
Gene). 
For the generation of flies with a deletion of the ry locus, two gRNA sequences were 
cloned into the pU6-BbsI-chiRNA plasmid (Addgene #45946) (Gratz et al. 2013). One gRNA 
targeted 5’ of the ry start site (5’-GGCCATGTCTAGGGGTTACG-3’) and the other targeted 3’ of 
the ry stop codon (5’-GATATGCACAGAATGCGCCT-3’). These were injected along with the 
pHsp70-Cas9 plasmid (Addgene #45945) (Gratz et al. 2013) into a w1118 stock (Best Gene). The 
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resulting ry deletion starts 373 bp upstream of the ry start codon and ends 1048 bp downstream 
of the ry stop codon. 
DNA damage survival assays 
Survival in the presence of DNA damaging agents was determined as in (Sekelsky 
2017). Five females and three males carrying heterozygous mutations for the indicated genes 
were allowed to mate and to lay eggs for 72 hours (untreated progeny), when they were moved 
to a new vial where they laid for 48 hours (treated progeny). The latter brood was exposed to 
1000 rads of ionizing radiation (source: 137Cs) or 10 μM camptocethin, diluted from a 
concentrated stock in a 10% ethanol, 2% Polysorbate 20 aqueous solution. The fraction of 
heteroallelic mutant flies in the treated progeny was divided by the fraction of heteroallelic 
mutant flies in the untreated progeny to calculate the survival. 
Statistical analysis 
Experiments that employ statistical tests as indicated in the figure legends were done 
using GraphPad Prism 6 (ANOVA) or Excel (Χ2 test). 
Cell lines 
Mouse Embryonic Fibroblasts (MEFs) were made from isogenic wt or Polq-null mice 
generated by conventional knock-out (Shima et al. 2004) that were obtained from Jackson 
Laboratories and maintained on a C57BL/6J background and immortalized with T antigen as 
described in (Yousefzadeh et al. 2014). Cells were incubated at 37 °C, 5% CO2 and cultured in 
DMEM (Gibco) with 10% Fetal Bovine Serum (VWR Life Science Seradigm) and Penicillin (5 
U/ml, Sigma). All lines used in this study were certified to be free of mycoplasma by a qPCR 
(Janetzko et al. 2014) with a detection limit below 10 genomes/ml. In addition, cell lines were 
randomly selected for third party validation using Hoechst staining (Battaglia et al. 1994). 
76 
Clonogenic survival assay 
Transfections were performed as in (Carvajal-Garcia et al. 2020a). Genome targeting 
ribonucleotide-protein complexes (RNP) were made by annealing the indicated crRNA (R26: 5’-
ACTCCAGTCTTTCTAGAAGA-3’, SLX4: 5’-ACAGCAGGAGTTTAGAAGGG-3’) to a tracrRNA 
(Alt-R, IDT) to form 8.4 pmol of gRNA, followed by incubation of annealed gRNA with 7 pmol of 
purified Cas9 (made after expression of Addgene #69090) (Lin et al. 2014). The assembled 
RNPs were electroporated into 200,000 MEFs along with 32ng of pMAX-GFP using the Neon 
system (Invitrogen) in a 10 ul tip with one 1,350 V, 30 ms pulse and plated (three 
electroporations formed one biological replicate). After 72 h, 500 cells were plated into 3 
different plates and let grow for 7 days to allow for colonies to form. Cells were fixed and stained 
as in [53], using a 6% glutaraldehyde, 0.5% crystal violet aqueous solution. Colonies were 
counted and survival was calculated for each cell line individually. Genomic DNA for the 
remaining cells was harvested and used as a template for the generation of a PCR product 
surrounding the R26 or the SLX4 break site. This PCR product was sequenced (Eton) and the 
editing efficiency was calculated using TIDE (Brinkman et al. 2014). The editing efficiencies for 
the SLX4 break site are noted in the figure; editing efficiencies for the R26 break site were 
84.7%, 95.7% and 95.3% for wt, Polq-/- and Polq-/- + POLQ respectively. 
Wing imaginal disc immunofluorescence 
The anterior halves of third instar larvae of third instar, 5-7-day old, homozygous mutant 
for the indicated genes, larvae were dissected in phosphate-buffered saline (PBS), everted, and 
fixed in 4% formaldehyde at room temperature for 45 min. They were washed three times in 
PBS+0.1% Triton-X (PBSTx), blocked in 5% normal goat serum for one hour at room 
temperature, and incubated overnight at 4°C in a 1:100 dilution of cleaved Dcp-1 antibody (Cell 
signaling #9578S) in PBSTx. Larva heads were then washed six times with PBSTx and 
incubated in a 1:500 dilution of secondary antibody (goat anti-Rabbit IgG, Alexa Fluor 488, Life 
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Technologies) for two hours at room temperature. After washing six times in PBSTx, DAPI was 
added at a 1:1000 dilution. Discs were dissected and mounted in 50 ul of Fluoromount G 
mounting media (Thermo).  
Pictures were taken with a Zeiss LSM880 confocal laser scanning microscope using a 
40X oil immersion objective with a constant gain and a 0.6X zoom using ZEN software. Images 
were saved as .czi files and were processed and the signal was quantified using ImageJ as in 
(Dewey and Johnston 2017). 
Mitotic crossover assay 
For Fig 2.6B, single males expressing Cas9 and the gRNA targeting the ry gene were 





















In addition, these males were heterozygous for st1 and e1 as well as for a SNP that 
changes the protospacer adjacent motif (PAM) sequence recognized by Cas9 immediately 
downstream of the gRNA sequence in ry (the chromosome with the mutation in st has the 
functional PAM and will be cut by Cas9). These males were crossed to females that were e1 
over TM6B, AntpHu Tb1 e1 ca1. To characterize the repair event that occurred after the DSB, a 
single male progeny, heterozygous for e and AntpHu, was crossed to females homozygous for a 
deletion in ry. If the non- AntpHu progeny has rosy eye color, the repair event was characterized 
as mutagenic end joining (EJ). If the non- AntpHu progeny had wild-type eye color, genomic DNA 
from a single male was extracted and the DNA surrounding the break was amplified by PCR. 
The presence of the silent mutation that changes the PAM sequence, revealed by resistance to 
cutting by BccI of the PCR product surrounding the Cas9 target site, was interpreted as HR. The 
presence of the intact PAM was characterized as unedited.  
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For Fig 6.2D and Table 3.1, single males as the ones described above and with 
maternal and zygotic mutations in the indicated genes (see crosses used to generate them 






























































































GenZ5997 mus312 Z1973 𝑠𝑡
𝐷f(3L)6103 mus312 D1 𝑒
 
 
Flies that were wild type for both markers or mutant for both markers were characterized 
as having a crossover event. 
Results 
Brca2 and POLQ mutations are synthetic lethal in Drosophila melanogaster 
During repair of double-strand breaks (DSBs) in mammals, TMEJ is able to compensate 
for some HR deficiencies (Fig 4.1A). This is best illustrated by the requirement of POLQ for the 
survival of BRCA1/2 mutant cancer cell lines (Ceccaldi et al. 2015; Mateos-Gomez et al. 2015), 
and the upregulation of POLQ in BRCA1/2 deficient breast and ovarian tumors (Lemée et al. 
2010; Ceccaldi et al. 2015; Carvajal-Garcia et al. 2020a). We therefore initially assessed 
whether a comparable phenomenon is evident at a whole animal level in Drosophila, by 
crossing flies heterozygous for mutations in PolQ and Brca2 (the Drosophila melanogaster 
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orthologs of POLQ and BRCA2; hereafter, the human gene/protein names will be used for 
simplicity) (Fig 4.1B). Homozygous mutant flies are easily identified due to the presence of a 
homologous balancer chromosome (CyO, Cy1 dplvl pr1 cn2 on the second chromosome and 
TM6B, AntpHu Tb1 e1 ca1 on the third chromosome) that carries a dominant phenotypic marker 
(Curly (Cy) for BRCA2, Humeral (AntpHu) for POLQ) (Fig 4.1B). When we looked at the progeny 
of these flies, we observed that single mutant flies in either gene alone displayed approximately 
100% viability (Fig 4.1C). Conversely, only 12% of the expected double homozygous mutant 
flies eclosed as adults, indicating semi-lethality when these two proteins are absent (Fig 4.1C). 
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Figure 4.1. The genetic interaction between POLQ and BRCA2 is conserved in 
Drosophila melanogaster. A) Schematic of the DSB pathways following end resection, 
including a partial list of proteins involved in each step. Synthetic lethal with Pol θ shown in 
red. B) Genotypes of the flies crossed to assess the viability of PolQ, Brca2, and PolQ Brca2 
mutants (left). Fraction of homozygous mutant flies observed and, in parentheses, expected 
by Mendelian genetics; the Cy and AntpHu markers, present in CyO and TM6B respectively, 
are recessive lethal. C) Observed survival of homozygous mutant files for the indicated genes 
expressed as percent of expected. Horizontal dashed line at Y=100 indicates 100% survival. 
N=696 (POLQ), 331 (BRCA2), 612 (POLQ BRCA2). 
 
Previous investigations have emphasized the strong genetic interaction between POLQ 
and genes involved in early steps of HR (i.e., steps preceding D-loop formation) (Fig 4.1A) 
(Ceccaldi et al. 2015; Mateos-Gomez et al. 2015; Feng et al. 2019). However, DNA 
intermediates formed downstream of end resection and strand invasion may also be amenable 
to repair by TMEJ. This has recently been suggested to be the case when long-range resection 
is impaired due to mutations in BRCA1, which may inhibit re-annealing of the unwound D-loop 
(Kamp et al. 2020). If so, mutations in genes involved in later steps of HR might also be 
synthetic lethal with POLQ mutations. Therefore, we assessed whether a genetic interaction 
exists between POLQ and genes encoding proteins involved in late steps of HR. 
Pol θ is required for viability in the absence of the Holliday junction resolvases 
We decided to use Drosophila melanogaster to investigate the genetic relationship 
between Pol θ and some of the latest acting HR proteins, the Holliday junction resolvases 
Mus312 (SLX4 in humans), and Gen (GEN1 in humans). Human SLX4 is a scaffolding protein 
that coordinates at least three endonucleases: SLX1, XPF-ERCC1, and MUS81-EME1 (the 
interaction with MUS81-EME1 has only been reported in mammals), forming the SMX tri-
nuclease (Fricke and Brill 2003; Andersen et al. 2009; Fekairi et al. 2009; Muñoz et al. 2009; 
Svendsen et al. 2009). GEN1 acts independently of SLX4 (Ip et al. 2008). These structure-
specific endonucleases have both unique and overlapping DNA substrate specificities (Chan 
and West 2015; Bellendir et al. 2017; Wyatt et al. 2017). 
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We assessed the viability of every double mutant combination (POLQ SLX4, POLQ 
GEN1, and SLX4 GEN1) as well as the triple mutant (POLQ SLX4 GEN1) by crossing 
heterozygous flies and comparing the fraction of adult homozygous mutant flies observed to 
what would be expected by Mendelian genetics. While POLQ SLX4, POLQ GEN1, and SLX4 
GEN1 double mutant combinations are fully viable, flies that lack Pol θ, SLX4, and GEN1 rarely 
progress to adulthood (<1% survival) (Fig 4.2A). When using the PolQnull allele over PolQZ2003 
(PolQZ2003 is a nonsense mutation reported to be a strong hypomorph; see methods), we 
observed a 3% survival for POLQ SLX4 GEN1 mutant flies (n=1059). This is, to our knowledge, 
the first evidence for synthetic lethality for POLQ and genes required for steps in HR after strand 
invasion. 
These results indicate a genetic redundancy between Pol θ and the resolvases. The 
functions of the resolvases suggested that the synthetic lethality could be due to a role for Pol θ 
in rescuing unresolved HR intermediates that arise from spontaneous DSBs, or stalled or 
broken replication forks. If this is the case, we reasoned such roles would be apparent as 
sensitivity to exogenous DNA damaging agents in double mutants that are viable in the absence 
of such agents. 
We used ionizing radiation to induce DSBs, and camptothecin, a type I topoisomerase 
poison, to generate stalled and broken replication forks. We compared the sensitivity of POLQ, 
SLX4, and GEN1 single mutants, as well as POLQ SLX4, and POLQ GEN1 double mutant flies, 
to moderate doses of ionizing radiation (1000 rads) and camptothecin (10 μM). All three single 
mutants showed an average survival of ≥80% for both DNA damaging agents (Figs 4.2B and 
4.2C). POLQ SLX4 double mutant flies showed the strongest reduction of viability, 31% and 9% 
survival when treated with IR or camptothecin, respectively (Figs 4.2B and 4.2C). POLQ GEN1 
double mutants showed only a modest reduction in viability. Pol θ is thus more important for cell 
viability in the absence of SLX4 than in the absence of GEN1. These results show that DSBs 
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and collapsed or broken replication forks generate DNA substrates, likely HR intermediates, that 
require the use of Pol θ or SLX4 for repair.  
 
Figure 4.2. POLQ is required for viability in the absence SLX4 and GEN1. A) Observed 
survival of homozygous mutant files for the indicated genes expressed as percent of 
expected. n=1126 (POLQ SLX4), 747 (POLQ GEN1), 257 (SLX4 GEN1), 448 (POLQ SLX4 
GEN1). Since POLQ, SLX4, and GEN1 are on the third chromosome, the balancer TM6B, 
AntpHu Tb1 e1 ca1 was used in these crosses. B), C) and D) Survival of flies exposed to 1000 
rads of ionizing radiation (B and D) or 10 μM camptothecin (C) homozygous mutant for the 
indicated genes with respect to the untreated progeny of the same parents. Each dot 
represents a vial pair. Horizontal dashed line at Y=100 indicates 100% survival. Error bars 
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represent 95% confidence intervals (CI). Statistical significance was assessed by one-way 
ANOVA with Bonferroni correction to account for multiple comparisons; ns, not significant; *, p 
<0.05. 
 
We also tested whether SLX1 or MUS81, two of the nucleases that associate with SLX4, 
played a more significant role than the other in the repair of these intermediates. We observed 
mild sensitivity to ionizing radiation of both POLQ MUS81 and POLQ SLX1 double mutants (Fig 
4.2D), reflecting an apparent redundancy between these two nucleases in the presence of SLX4 
and GEN1. Interestingly, POLQ MUS81 GEN1 triple mutant files are much more sensitive to IR 
(1% survival) than POLQ SLX1 GEN1 triple mutant flies (50% survival) (Fig 4.2D), which 
suggests that MUS81 is required for the repair of certain DNA substrates in the absence of 
GEN1. 
Next, we addressed whether this genetic interaction observed in flies is conserved in 
mammals. For this, we used T-antigen transformed mouse embryonic fibroblasts (MEFs) 
derived from isogenic wild type (wt) and Polq-/- mice (Shima et al. 2004). In addition, we used 
Polq-/- MEFs that have been complemented with the human POLQ cDNA (Yousefzadeh et al. 
2014). We electroporated ribo-nucleoprotein complexes of purified Staphylococcus pyogenes 
Cas9 protein with gRNAs targeting either the non-protein-coding Rosa26 locus (control locus, 
R26) or exon 4 in SLX4 (Fig 4.3A). 72 hours later, we assayed cell viability by a colony 
formation assay. In addition, we harvested DNA from the cells, amplified the genomic regions 
across the Cas9 site and used tracking of indels by decomposition (TIDE) (Brinkman et al. 
2014) to calculate the fraction of chromatids that had an indel at the target sites (% editing) (Fig 
4.3A). Targeting SLX4 did not decrease viability in wt or in complemented Polq-/- MEFs 
compared to targeting the non-coding locus (Fig 4.3B, Fig 4.4). However, we observed a 54% 
reduction in viability in the Polq-/- MEFs when targeting SLX4, relative to the control locus, which 
matches the editing efficiency of 58% in that cell line (Fig 4.3B, Fig. 4.4). Unlike flies, this 
decrease in viability in POLQ SLX4 double mutants MEFs is observed in the absence of 
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exogenous DNA damage (except for the DSB made by Cas9), arguing the genetic interaction 
between POLQ and SLX4 is stronger in mammalian cells than it is in flies. 
 
Figure 4.3. Genetic interaction 
between POLQ and SLX4 in 
mouse cell culture. A) wt, Polq-/- 
and complemented Polq-/- MEFs 
were electroporated with Cas9 
targeted with a gRNA to the 
Rosa26 (R26) locus or to Slx4. 72 
hours later, 500 cells were plated 
into each of three plates to assay 
viability. Genomic DNA from the 
remaining cells was used as a 
template for amplification around 
the breaks. PCR product was 
sequenced and editing efficiency 
was calculated with TIDE. B) 
Survival after Cas9 cleavage 
targeted by the SLX4 gRNA, 
relative to the R26 gRNA for each 
cell line. Editing efficiency is 
indicated above the graph. Error 
bars represent standard error of 
the mean, n=3 biological 
replicates. Statistical significance 
was assessed by one-way 
ANOVA with Bonferroni correction 
to account for multiple 





Figure 4.4. Colony formation 
assay plates. Representative 
images of one plate per condition 
(genotype and gRNA) scored for 
Figure 4.3B. 
  
Lack of Pol θ and resolvases leads to high levels of apoptosis  
Interestingly, etched tergites (disrupted tissue patterning in the abdomen) could be 
readily observed in most POLQ SLX4 double mutant flies (88.1%, n=42) (Fig 4.5A). These are 
indicative of defects in cell survival or proliferation during development. We never observed 
them in wt (n=71) and POLQ mutants (n=40) and rarely in the SLX4 ones (18.2%, n=44). This 
phenomenon has been described in POLQ RAD51 double mutants (Chan et al. 2010). 
To accurately quantify the level of apoptosis in flies with different genotypes, we used an 
antibody that detects cleaved Dcp-1, a marker of apoptosis in Drosophila (Song et al. 1997). We 
immunostained larval wing imaginal discs, a highly proliferative tissue that becomes the adult 
wings after metamorphosis. The use of a larval tissue also allows us to assess the levels of 
apoptosis in POLQ SLX4 GEN1 flies, at least in the fraction of animals that reach the larval 
stage. We observed very little apoptosis in POLQ mutant flies, while levels of apoptosis were 
significantly higher in POLQ SLX4, and even higher in the POLQ SLX4 GEN1 triple mutant 
(Figs 4.5B and 4.5C). This is consistent with the reduction in viability observed in the POLQ 
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SLX4 GEN1 triple mutant, as well as sensitivity to exogenous DNA damage by IR or 
camptothecin in the POLQ SLX4 double mutant. 
 
Figure 4.5. POLQ SLX4 GEN1 flies have 
high levels of apoptosis. A) Images of 
representative POLQ mutant and POLQ 
SLX4 mutant female flies. For the bottom 
pictures, the wings and legs were removed. 
B) Images of representative wing imaginal 
discs from third instar larvae of the indicated 
genotypes stained with an anti-Dcp1 
antibody (green) and DAPI (blue). C) 
Quantification the Dcp-1 signal expressed as 
the percent of the area of Dcp-1 within each 
disc. Error bars represent 95% CI. Statistical 
significance was assessed by one-way 
ANOVA with Bonferroni correction to account 




Pol θ suppresses mitotic crossovers 
The strong genetic interaction between Pol θ and the resolvases suggests the existence 
of a DNA intermediate that will either be joined by TMEJ or progress to a double Holliday 
junction and be resolved by SLX4 or GEN1. This DNA intermediate, when left unrepaired, 
causes cell death. We hypothesize that this substrate is an HR intermediate. In Drosophila 
somatic cells, both TMEJ and Holliday junction formation are downstream of the preferred HR 
pathway, SDSA. Support for this hypothesis comes from the finding that Pol θ-dependent end 
joining products and mitotic crossovers are both increased when SDSA is inactive due to the 
absence of the BLM helicase (Adams et al. 2003; McVey et al. 2007). This leads to a model in 
which DNA intermediates formed after aborted SDSA can then be processed by either TMEJ or 
the structure-specific endonucleases. In the absence of both pathways, these DNA 
intermediates accumulate and become toxic to cells, which ultimately undergo apoptosis; high 
levels of apoptosis lead to organismal death. 
We set out to identify potential consequences of the epistatic relationship between TMEJ 
and Holliday junction resolution described above by designing a DSB repair assay in Drosophila 
that allows for assessment of an expected product of Holliday junction resolution, mitotic 
crossovers (Fig 4.6A). DSBs are generated in the germline cells of male flies by expressing 
Cas9 under a germline promoter (nos), and a gRNA, expressed with the U6 promoter, targeting 
the coding region of the rosy (ry) gene, located in the right arm of chromosome 3. Homozygous 
ry mutant flies are viable and have an easily identifiable mutant eye color. Only the maternal 
chromosome gets cut, as the paternal allele harbors a SNP that alters the PAM sequence (TGG 
becomes TGA) required for recognition and cleavage by Cas9 (Fig 4.6A).  
This assay allows us to detect mutagenic end joining, homologous recombination events 
that used the homologous chromosome as a template, and unedited (never cut or precisely 
repaired) chromosomes. Moreover, we can characterize HR events as crossovers or non-
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crossovers due to the presence of the phenotypic markers scarlet (st) and ebony (e), as well as 
the fact that Drosophila males don’t generate crossovers during meiosis (McVey et al. 2007).  
We performed this assay using 60 single males, six of which were sterile. We randomly 
selected one progeny fly from each of the 54 remaining males, and detected editing in 40 
(74%), showing that the assay is highly efficient (Fig 4.6B). In wild-type flies we observed that 
repair of a DSB by end joining (EJ) and HR are roughly equally common (EJ: 21/54, 39%; HR: 
19/54, 35%) (Fig 4.6B).  
 
Figure 4.6. Pol θ suppresses mitotic crossing over. A) Third chromosomes (maternal, ♀, 
and paternal, ♂) of a male fly expressing Cas9 and a gRNA targeting the ry gene, and 
heterozygous for the markers st and e. The PAM sequence for the gRNA in the maternal 
chromosome, and lack thereof in the paternal one, is indicated. Wild-type ry (+) in the 
maternal chromosome indicates either unedited (if PAM is present) or HR repair (if PAM is 
absent). Mutant ry (-) indicates repair by mutagenic end joining. B) Percent of chromosomes 
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repaired by HR, EJ, or unedited, calculated by assessing the ry and PAM status. n=56. C) 
Third chromosomes of a male fly described in panel A before and after the generation of a 
mitotic crossover. D) Percent of total progeny that were recombinant is indicated for each 
genotype. Males were maternal and zygotic mutants for the indicated genes. Number of 
males crossed: 97 (wild type), 55 (POLQ), 62 (SLX4), 60 (GEN1), 69 (SLX4 GEN1). Number 
of progeny scored: 8790 (wild type), 3471 (POLQ), 5016 (SLX4), 6830 (GEN1), 3446 (SLX4, 
GEN1). Error bars represent 95% CI. Statistical significance was assessed by one-way 
ANOVA with Bonferroni correction to account for multiple comparisons; ns, not significant; *, p 
<0.05. 
 
Mitotic crossovers are present in only 0.2% of wild type flies (Figs 4.6C and 4.6D); 
strikingly, they are present at 18-fold higher levels in POLQ deficient flies (Fig 4.6D). 
Interestingly, ablation of all resolvase activity (i.e., both SLX4 and GEN1) was required to 
completely eliminate mitotic crossing over. This is in contrast to mitotic crossovers generated in 
the absence of the anti-crossover helicase FANCM, which depend solely on SLX4 (Kuo et al. 
2014), and are likely not originated by a blunt DSB like the ones in this assay. 
Because nos is expressed early in the male germline, it should be noted that repair 
events might be amplified unevenly during cell proliferation prior to spermatogenesis. Even 
though we don’t expect this to disproportionately affect different genotypes, we analyzed these 
results in a different way by assessing only whether each male had some crossover progeny or 
no crossover progeny. The results of this analysis mirrored those in the previous one, though 
the magnitude of the change was lower (3.5X more mitotic crossovers in POLQ mutant flies 
than in wt flies) (Table 2.1). This latter analysis is definitively unaffected by unequal expansion, 
but presumably underestimates the amount of crossing over due to our inability to distinguish 
between one and multiple crossover events in the same male germline. 
These results show that the absence of Pol θ increases the amount of mitotic crossing 
over during HR. Moreover, our results imply that Pol θ can act upstream of the Holliday junction 
resolvases, and thus presumably upstream of Holliday junction formation as well. 
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Table 2.1: Mitotic crossing over is increased in POLQ mutant flies 
Genotype 
MCOs p (Χ2 with Yate’s 
correction) Yes No 
wt 5 92 N.A. 
POLQ 10 45 0.021 
SLX4 7 55 0.26 
GEN1 6 54 0.40 
SLX4 GEN1 0 69 0.15 
Crosses from for Figure 4.6D were characterized as having any progeny with a mitotic crossing 
over (Yes) or no progeny with a mitotic crossover (No). p-value for each mutant genotype when 
compared to wt was calculated with a Χ2 test applying the Yates correction. 
 
Discussion 
Pol θ has the ability to compensate for the loss of BRCA1 and BRCA2, key mediators of 
HR, as well as for loss of proteins involved in NHEJ (Ceccaldi et al. 2015; Mateos-Gomez et al. 
2015; Wyatt et al. 2016). Moreover, a recent synthetic lethality screen uncovered 140 genes 
that have a synthetic growth defect with POLQ, most of which operate outside of DSB repair, 
and showed that as much as 30% of breast tumors may be relying on Pol θ for survival (Feng et 
al. 2019). This ability has motivated the search for a Pol θ inhibitor for treatment of cancer 
(Schrempf et al. 2021). 
However, no HR gene outside of the resection/strand invasion step has been shown to 
be synthetic lethal with POLQ. Here we show that flies deficient in Pol θ, SLX4, and GEN1 – the 
latter of two acting late during HR – are inviable, due to high levels of apoptosis likely caused by 
endogenous DNA damage, and that flies with mutations in POLQ and SLX4 are hypertensive to 
the DNA damaging agents IR and camptothecin. Moreover, we demonstrate that the genetic 
interaction between Pol θ and SLX4 is conserved in mice. This striking genetic redundancy 
strongly suggests that TMEJ and Holliday junction formation/resolution are involved in 
processing similar DNA substrates. 
The ability of Pol θ to rescue deficiencies in HR genes is not completely understood. A 
well-defined starting substrate for TMEJ is generated after 5’ resection of both ends of a DSB 
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(Yousefzadeh et al. 2014; Wyatt et al. 2016), yet it is not known whether that is the only 
substrate used by Pol θ. Two 3’ ssDNA tails are also the starting substrate in HR, implying a 
possible competition between TMEJ and HR. The difficulty in accurately measuring the different 
outcomes of HR in mammalian cells has led to conflicting evidence on whether Pol θ has the 
ability to suppress HR, and therefore compete for a starting substrate (Ceccaldi et al. 2015; 
Mateos-Gomez et al. 2015; Wyatt et al. 2016). 
Well characterized assays in Drosophila allow for the unambiguous assessment of 
SDSA, the major pathway for completion of repair by HR in somatic cells (Adams et al. 2003), 
and they show that lack of Pol θ doesn’t affect the frequency of DSB-induced SDSA (Chan et al. 
2010). Pol θ deficiency similarly doesn’t affect the frequency of single strand annealing, another 
pathway immediately downstream of end resection, in flies or in human cells (Wei and Rong 
2007; Kelso et al. 2019). This argues that Pol θ does not compete for the 3’ ends generated by 
5’ end-resection.  
In contrast, Pol θ suppresses mitotic crossovers and is synthetic lethal with resolvase 
deficiency, arguing it does compete for repair by the alternate means for completion of HR that 
involves a double Holliday junction. SDSA is upstream of TMEJ and Holliday junction 
formation/resolution, yet both Pol θ-associated indels and mitotic crossovers are observed in 
wild-type flies. This indicates that sometimes SDSA either fails or cannot be completed. We 
propose that the remaining DNA intermediate(s) can either be joined by Pol θ, generating a 
small indel, or can progress to a double Holliday junction, that may be resolved to create a 
mitotic crossover. 
Thus, though the generation of small indels is implicit to repair by TMEJ, this pathway 
protects against potentially more deleterious forms of repair, such as larger deletions (Carvajal-
Garcia et al. 2020a), or interhomolog recombination after a DSB is made in both homologs 
(Davis et al. 2020). Holliday junction resolution also generates genotypes, in the form of loss of 
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heterozygosity, that can affect whole chromosome arms. The high potential pathogenicity of 
these events may make them more detrimental to cells than small indels, supporting Pol θ’s role 
in maintaining genomic stability. 
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CHAPTER 5: DISCUSSION 
 
“Burn me in the desert and drown me in the rain 
Throw me to the thunder push me out of the plane 
I don't feel afraid anymore 
I'm a warrior” 
−Raye Zaragoza 
Introduction 
A stable genome is a requirement for life. However, the DNA of all organisms is 
constantly being damaged. For this reason, all organisms have the ability to recognize and 
efficiently repair damage in their DNA. 
Of all the different types of damage that affect DNA, chromosome double strand breaks 
(DSBs) are one of the most toxic and difficult to repair. DSBs need to be repaired for cells to 
survive, and misregulation in the DSB repair processes can lead to loss of genomic information, 
chromosome rearrangements, carcinogenesis, and cell death. Eukaryotes use two main 
pathways to repair DSBs, non-homologous end joining (NHEJ) and homologous recombination 
(HR), which are most commonly error-free. However, there is a third, error-prone pathway that 
can repair chromosome breaks, and that is polymerase theta-mediated end joining (TMEJ). 
In my time in graduate school I have studied TMEJ taking a wide approach. My thinking 
has ranged between the angstrom scale – assessing how the ability to form small stretches of 
base pairing influences repair by Pol θ – and the meter scale – the study of whole animals: flies 
and human cancer patients. I have taken advantage of the different approaches I had available 
to answer different questions about TMEJ, sometimes even trying to answer the same question 
from two very different directions. 
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For the mechanistic studies described in Chapters 2 and 3, I exploited our ability to have 
mouse cells join double strand breaks with very specific end structures and sequence contexts, 
both in the chromosome and using extrachromosomal substrates. To study the genetic 
relationship between TMEJ and HR, described in Chapter 4, I took advantage of the model 
organism Drosophila melanogaster, or fruit flies, which allows us to do genetic experiments that 
would be unthinkable in mammals. In this discussion chapter, I will summarize the discoveries I 
have made, and I will give my opinion on which are the most interesting outstanding questions 
regarding TMEJ 
Mechanism of polymerase theta-mediated end joining 
When I started graduate school, we had a model for how TMEJ should work, an idea on 
how a DNA polymerase could repair a chromosome break. To repair two 3’ resected DNA ends 
by an end joining mechanism, Pol θ had to couple four steps: 1) substrate recognition, 2) 
microhomology search, 2) cleavage of non-homologous 3’ tails and, 4) synthesis of DNA to 
resolve the break (Fig. 5.1). However, this model provided as many questions as it did answers. 
Just to name a few: What do Pol θ biological substrate(s) look like? How does the 
microhomology search happen? What is the role of the helicase domain of Pol θ? What 
happens if there are no microhomologies available in the 3’ tails? Which nuclease is responsible 
for the cleavage of the tails? Does TMEJ involve strand displacement synthesis? Is synthesis by 
Pol θ unidirectional or bidirectional? More than five years later, I can say that I have answered 
some of these questions, but certainly not all of them.  
Regarding the biologically relevant substrate(s) of Pol θ, it is now clear that there are 
multiple. The better understood one is two 3’ ssDNA tails, that are naked of ssDNA proteins that 
promote HR – RPA and RAD51 (Fig. 5.1). How often this substrate is available to Pol θ is 
unknown, but it is likely not common, due to the high levels and affinity of RPA for ssDNA. 
There are other ssDNA binding proteins in mammalian cells that could allow for Pol θ-
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dependent repair, such as HMCES, which promotes a-EJ in certain circumstances (Shukla et al. 
2020), but a direct link with TMEJ is still lacking. The inhibition of TMEJ by RPA and RAD51 
suggests that Pol θ cannot compete with HR, but rather acts as a backup when it fails. This 
hypothesis is addressed in Chapter 4 and will be examined later in the discussion 
 
Figure 5.1. Molecular mechanism of polymerase theta-mediated end joining. Schematic 
of the molecular mechanism that leads to the three types of Pol θ-dependent products. 
 
Pol θ’s role in the repair of replication associated breaks implies that there is another 
class of substrates that it can use, intermediates after replication fork collapse (Koole et al. 
2014; Ceccaldi et al. 2015; Deng et al. 2019). In Chapter 3 it is shown that a substrate that 
mimics a replication fork collapse intermediate can be efficiently joined by Pol θ. 
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The use of microhomologies is central to TMEJ, and how they are found determines the 
consequences and the success of this pathway (Fig. 5.1). Chapter 2 is devoted to the 
microhomology search process. It describes how Pol θ begins searching from the 3’ end, and 
moves inwards, looking for a >2 bp microhomology within 10-15 nt. This strategy minimizes the 
size of deletions associated with TMEJ, and is successful on >85% of sequence contexts. On 
the rest, those where microhomologies are not present with 10-15 nt of ssDNA, Pol θ can 
synthesized de novo microhomologies, either performing snap-back, intramolecular synthesis, 
or transient intermolecular synthesis followed by disassembly (Fig. 5.1). The multiple rounds of 
synthesis create templated insertions (TINS), a mutational signature that is highly characteristic 
of TMEJ (Schimmel et al. 2019). In accordance we found that TINS correlate with POLQ 
expression in breast tumors, and are increased in BRCA1/2 mutated cancers. It is important to 
note that snap-back synthesis leads to unproductive repair, and therefore needs to be 
suppressed. Two mechanisms that possibly contribute to this suppression involve the helicase 
domain of Pol θ as well as its newly described nuclease activity (Fig. 5.1) (Black et al. 2019; 
Zahn et al. 2021). 
TMEJ involves a nucleolytic step that allows for microhomology primed-synthesis (Fig. 
5.1). While I have been unable to identify the nuclease responsible for this step, I characterize 
its cleavage mechanism in Chapter 3, and determined that it begins cutting from the 3’ end and 
therefore it is likely an exonuclease. Pol θ could be responsible for this step, which would allow 
for perfect coupling of the nuclease and the synthesis steps. However, its in vitro substrate 
specificity does not match my observations in vivo. Of the 3’ exonucleases available in the cell 
that I favor is the 3’ proofreading exonuclease activity of Pol δ. Pol δ is responsible for a-EJ in 
yeast (Meyer et al. 2015), where Pol θ is missing, and it has been suggested to be involved in 
TMEJ in worms and in a-EJ in human cells (Kamp et al. 2020; Layer et al. 2020). 
Last, Pol θ uses the annealed microhomology to prime DNA synthesis. It remains 
unknown if Pol θ synthesizes the dozens of nucleotides that are needed to resolve the break. As 
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explained above, Pol δ has been implicated in this pathway, and a polymerase switch would be 
of interest to the cell, as synthesis by Pol θ is error-prone (Arana et al. 2008). Chapter 3 shows 
that TMEJ involved the displacement of the non-template strand, making it a long patch repair 
pathway. It remains unclear whether Pol θ can do strand displacement synthesis (Kent et al. 
2015; He and Yang 2018), yet a polymerase switch between Pol θ and Pol δ could explain this 
observation. Pol θ could conceivably synthesize DNA bidirectionally using the same 
microhomology. However, the current evidence points to unidirectional synthesis, since in the 
formation of templated insertions, newly synthesized, secondary microhomologies anneal to 
sequences 3’ of the primary microhomology (Fig. 5.1). 
Genetics of polymerase theta-mediated end joining. 
TMEJ is required for cell and organism viability in the absence of different DNA repair 
pathways, a phenomenon known as synthetic lethality (Ceccaldi et al. 2015; Mateos-Gomez et 
al. 2015; Feng et al. 2019). Fruit flies represents an ideal model system to study genetic 
interactions, and not surprisingly the concept of synthetic lethality was first described in 
Drosophila (Dobzhansky 1946). In addition, studies in Drosophila have a history in determining 
new and specific functions of genes in DNA repair pathways, most importantly for this work, the 
role of Pol θ in chromosome break repair (Adams et al. 2003; Chan et al. 2010; Holsclaw and 
Sekelsky 2017; Carvajal-Garcia et al. 2020b). For these reasons, flies are an ideal model 
organism for expanding the list of genes and pathways synthetic lethal with Pol θ, and 
consequently improve our knowledge of the roles of TMEJ in maintaining genomic stability. 
 The genetic interaction between TMEJ and HR has been intensely studied (Ceccaldi et 
al. 2015; Mateos-Gomez et al. 2015; Feng et al. 2019), yet all of the genes involved in HR that 
have been shown to be synthetic lethal with POLQ are part of the early steps of HR. It is 
reasonable to think that this would also be the case for genes acting in late HR, as failure of to 
complete HR due to mutations in genes involved in the later steps is predicted to lead to toxic 
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DNA intermediates that could be resolved by Pol θ. Chapter 4 shows that this is the case, as 
flies deficient in the Holliday junction resolvases SLX4 and GEN1 are inviable, and so are 
mouse cells lacking SLX4 and Pol θ. Both Holliday junction resolution and TMEJ are a back up 
to the main form of HR, SDSA, yet lack of both back up pathways leads to lethality. 
We interpret this result the following way: SDSA sometimes fails to complete, and the 
resulting DNA intermediate can either be joined by TMEJ or progress to a double Holliday 
junction and get resolved by SLX4 or GEN1. Therefore, TMEJ and Holliday junction resolution 
share a substrate that, when it doesn’t get repaired, leads to cell death. 
In order to determine if TMEJ is upstream of resolution, we designed an assay in flies 
that detects mitotic crossovers, which are formed by SLX4 and GEN1, after a chromosome 
break. Flies deficient in Pol θ show a large increase in mitotic crossing over, showing that TMEJ 
prevents their formation. This could seem counter-intuitive, as TMEJ is an error-prone pathway 
and HR is generally considered error-free, but mitotic crossovers between homologs cause loss 
of heterozygosity in very large areas of the chromosomes, and have been shown to lead to 
cancer (Zhu et al. 1992; Luo et al. 2000). We propose that the small deletions and insertions 
made by TMEJ are normally less pathogenic than loss of heterozygosity is whole chromosome 
arms. 
This is a common feature of TMEJ. Even if it is an error-guaranteed pathway, its use 
prevents larger deletions (Wyatt et al. 2016; Carvajal-Garcia et al. 2020a; Zhang et al. 2021), 
chromosome rearrangements (Wyatt et al. 2016; Hwang et al. 2020), and loss of heterozygosity 
(Davis et al. 2020; Carvajal-Garcia et al. 2021), all of them potentially more detrimental than the 
small loss of genetic information associated with TMEJ. This helps explain its high conservation, 
as Pol θ present in almost all eukaryotes (Takata et al. 2017). 
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Future directions 
Despite the interest that TMEJ has sparked in the last 5 to 10 years, multiple questions 
still prevent its full understanding. 
How Pol θ gets recruited to DNA breaks remains unknown. PARP-1 has been suggested 
to play a role (Mateos-Gomez et al. 2015), as well as FANCD2 (Kais et al. 2016). However, 
Pol θ knock down further sensitizes BRCA2 deficient tumors to a PARP inhibitor, and POLQ 
and FANCD2 are synthetic lethal, which partially contradicts these observations (Ceccaldi et al. 
2015). In addition, nothing in known about how TMEJ is regulated, and kept as a rarely used 
repair pathway in cells. Recently, two reports have shown a link between TGFβ signaling and 
POLQ expression and repair of chromosome (Liu et al. 2018, 2021) breaks by TMEJ, but 
without a mechanistic explanation. 
In addition, and as discussed above, the determination of more biologically relevant 
substrates for TMEJ should be an area of active investigation. In mammalian cells it remains 
unclear whether Pol θ has the ability to compete with HR, or it is purely a backup pathway 
(Ceccaldi et al. 2015; Mateos-Gomez et al. 2015; Wyatt et al. 2016; Zelensky et al. 2017; 
Hwang et al. 2020). This is likely due to the difficulty of measuring HR in a way that mimics what 
naturally happens in cells, as this pathway is error-free. Understanding in which contexts Pol θ 
competes with the HR machinery, if any, could provide a clearer picture on the biological 
importance of Pol θ. 
Most of our knowledge of how Pol θ repairs chromosome breaks comes from the study 
of two-ended DSBs, made by the excision of a P-element (Chan et al. 2010; Van Schendel et al. 
2015; Beagan et al. 2017), or by the I-SceI and Cas9 nucleases (Van Schendel et al. 2015; 
Wyatt et al. 2016; Feng et al. 2019; Kelso et al. 2019; Carvajal-Garcia et al. 2020a). Even 
though the involvement of Pol θ in the repair of replication-associated breaks is clear (Roerink et 
al. 2014; Ceccaldi et al. 2015; Deng et al. 2019; Feng et al. 2019; Wang et al. 2019), how Pol θ 
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repairs stalled and collapsed replication forks remain poorly understood. The different nature of 
replication-associated substrates may require a different Pol θ-dependent mechanism, or a 
different set of accessory factors. Understanding the role Pol θ in replication is key, as 
replication-associated breaks are more common than two-ended chromosome breaks, and are 
likely behind most of the synthetic lethalities associated with Pol θ loss (Feng et al. 2019). 
Pol θ remains the only protein that has been directly linked to TMEJ. The description of 
other factors required for this pathway would help understand how TMEJ operates and how it is 
regulated. Many proteins have been suggested to play a role in a-EJ and/or TMEJ, other than 
Pol θ: the ligases LIG3 and LIG1, the nucleases FEN1 and XPF, and, as described above, Pol δ 
(Ahmad et al. 2008; Simsek et al. 2011; Boboila et al. 2012; Mengwasser et al. 2019). Directly 
linking any one of these to TMEJ would greatly increase our understanding of this pathway. 
Last, the strong genetic interaction between POLQ and BRCA1/2 has made it an 
incredibly exciting protein to study in the context of cancer (Higgins and Boulton 2018; Schrempf 
et al. 2021). Inhibition of Pol θ could be, in theory, a perfect cancer treatment, as there are many 
tumors that rely on Pol θ for survival while TMEJ is rarely used in normal cells. However, we 
need to better understand Pol θ’s role in the cell. Because we don’t fully know all the processes 
that involve Pol θ, we don’t understand all the possible side effects an inhibitor would have on a 
patient. In addition, it is common for tumors to develop resistance to drugs, and this may also be 
the case for a Pol θ inhibitor. Pol θ may be an attractive target for the treatment of certain 
cancers, but we won’t be able to appreciate its true potential until more research has been done 
and less questions are outstanding 
Conclusions 
Holistically, this dissertation describes work utilizing Genetics, Molecular Biology, and Cell 
Biology approaches to increase our understanding of TMEJ, a fundamental biological process 
that is highly relevant in the context of cancer. Combining mechanistic studies in cell culture with 
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the power of fly genetics, allowed for a comprehensive and synergistic understanding of TMEJ. I 
consider, and I hope that anyone reading this document agrees, that the work presented here 
improves our understanding of TMEJ in particular, and chromosome break repair in general.  
If you got to here, there is only one more thing for me to say: Thank you. 
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APPENDIX: THE DROSOPHILA MELANOGASTER ORTHOLOG OF RFWD3 FUNCTIONS 
INDEPENDENTLY OF RAD51 DURING DNA REPAIR3 
 
Introduction 
DNA damage repair consists of a set of processes that detect and fix changes in the 
DNA molecules of cells; DNA repair is required for cell and organismal viability. Drosophila 
melanogaster has been an important model in the discovery of genes involved in DNA damage 
repair (Sekelsky 2017). In the 1980s and 1990s, dozens of mutants hypersensitive to the DNA 
alkylating agent methyl methanesulfonate (MMS) were isolated (mutagen-sensitive genes, mus) 
(Boyd et al. 1981; Mason et al. 1981; Laurencon et al. 2004). Mapping and characterization of 
these mutants has led to important insights into DNA repair mechanisms not only in fruit flies but 
also in humans (Andersen et al. 2009; Chan et al. 2010). However, the majority of these 
mutations have yet to be characterized (e.g., 20 of 27 on chromosome 3), providing a useful 
resource to continue improving our understanding of DNA repair. In this study, we map one 
these uncharacterized complementation groups, mus302, and show that the gene encodes the 
ortholog of the human RING finger and WD domain protein 3 (RFWD3).  
RFDW3 is an E3 ubiquitin ligase that targets the single-stranded DNA binding protein 
Replication Protein A (RPA) (Liu et al. 2011; Elia et al. 2015), the recombinase RAD51 (Inano et 
al. 2017) and the tumor suppressor p53 (Fu et al. 2010)after DNA damage in humans. The fate 
of the ubiquitylated proteins is not clear, as different groups report different conclusions (Elia et 
al. 2015; Inano et al. 2017). In humans, RFWD3 has been shown to be involved in the restart of 
hydroxyurea (HU)-stalled replication forks, the repair of Tus/ter collapsed forks through 
homologous recombination (HR), as well as repair of I-SceI-mediated double-strand breaks 
(DSBs) (Elia et al. 2015). Human cells deficient in RFWD3 are also hypersensitive to the DNA 
 
3 This chapter is adapted from published work: The original citation is as follows: Carvajal-Garcia J. et al. 
The Drosophila melanogaster Ortholog of RFWD3 Functions Independently of RAD51 During DNA 
Repair. G3 (Bethesda). 2020 Mar 5;10(3):999-1004. 
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crosslinking agent mitomycin C (MMC), ionizing radiation (IR), and (Feeney et al. 2017; Inano et 
al. 2017). RFWD3 mutant cells exhibit increased foci of RPA and RAD51 when treated with 
MMC (Feeney et al. 2017). Consistent with these observations, RFWD3 localizes to replication 
forks in a proliferating cell nuclear antigen (PCNA)-dependent manner (Lin et al. 2018). In 
addition, RFWD3 is phosphorylated by the DNA damage response kinase ATR (and possibly 
ATM) (Fu et al. 2010; Feeney et al. 2017), and this may be required for its function. Finally, 
patients biallelic for inactivating mutations in RFWD3 display Fanconi Anemia-like symptoms, so 
this gene has also been named FANCW (Knies et al. 2017). 
Here we show that flies with mutations in mus302 display no hypersensitivity to HU or 
IR, suggesting that Mus302 is not involved in the repair of collapsed replication forks or DSBs, 
despite its orthology to RFWD3. Moreover, these flies have no apparent defects in a gap repair 
assay of synthesis-dependent strand annealing (SDSA), one of the most common pathways for 
homologous repair of DSBs. We also provide evidence that Mus302 acts independently of the 
Drosophila ortholog of RAD51 (Spn-A) in repair of DNA damage caused by MMS. Last, we 
observe that two known ATR phosphorylation sites in human RFWD3 are missing in Mus302, 
consistent with a role of this protein in DNA repair outside of S phase. Taken together, our 
findings show that the Drosophila ortholog of RFWD3 functions differently from the human one, 
suggesting it may be used to reveal new roles of the protein in humans.  
Materials and methods 
Drosophila stocks 
Drosophila stocks were kept at 25°C on standard cornmeal medium. Flies with mutant 
mus302 alleles were obtained from the Bloomington Drosophila Stock Center (BDSC) and are 
described in (Boyd et al. 1981) and (Laurencon et al. 2004) (mus302D1, mus302D2, mus302D3, 
mus302Z1882, mus302Z4933 and mus302Z6004). To generate a wild-type CG13025 transgene, the 
coding sequence plus the intron of this gene was amplified by PCR with 1187 bp upstream of 
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the ATG and 271 bp downstream of the stop codon (primers: 5’-
GGTTCGGTCATGGCTTTCTTAC-3’ and 5’-TGAATGCTCAAAGTCTGTTGTGGA-3’) and 
cloned into a plasmid containing an attB site and a w+ gene (Addgene #30326). The plasmid 
was injected into the Bloomington stock number 9738 (y1 w1118; PBac{y+-attP-9A}(VK00020) 
(Genetivision) and two independent isolates (A and B) were generated. The 3L deficiency 
stocks Df(3L)ED4606 (deletes 16,087,484-16,780,123) and Df(3L)ED4674 (deletes 16,661,284-
17,049,418) were obtained from BDSC (stock numbers 8078 and 8098). spn-A057 and spn-A093A 
mutations are described in (Staeva-Vieira et al. 2003). 
DNA damage sensitivity assays 
Sensitivity to DNA damaging agents was assessed as in (Holsclaw and Sekelsky 2017; 
Sekelsky 2017). Three males and five females heterozygous for the indicated mutations were 
crossed and allowed to lay eggs for three days (untreated brood). They were then transferred 
into a new vial and allowed to lay eggs for two days (treated brood). The treated brood was 
exposed to the indicated dose of methyl methanesulfonate, hydroxyurea or ionizing radiation 
(source: 137Cs). The fraction of homozygous mutants for both broods was calculated per vial. 
Survival was calculated as the fraction of homozygous mutants in the treated brood over the 
fraction of homozygous mutant in the untreated brood. 
Allele amplification and sequencing 
For sequencing the coding region of CG13025 in flies with mutant mus302 alleles, each 
allele was crossed to the deficiency line Df(3L)ED4606 and DNA was extracted from a male as 
in (Adams et al. 2003). CG13025 was amplified with the high-fidelity polymerase PrimeSTAR 
HS (Takara) (primers: 5’-ATCTCGATCTTGACCATCCCTAGC-3’ and 5’-TCCACAACAGACTTT 
GAGCATTCA-3’) and sequenced by Sanger sequencing (Eton) with the two primers used for 
amplification plus 5’-CGAGCATCGACTGGTCTCG-3’. Sequences from the mutant alleles were 
compared to the presumed original wild-type alleles in flies from the corresponding screen by 
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sequencing CG13025 from the mus312D1 and mus312Z1973, which were isolated in the same 
screens. Allele-specific PCRs were developed for the mus302D1 (5’-
CCAAGCACTCCATGCTGAA-3’ and 5’-AGAATGTAAGGGCCGTAAGT-3’) and the mus302Z1882 
(TAGAGATATCCGTCATCTGTGA and GTAGGTGGATCAATAAAGCG) to identify specific 
mus302 alleles in recombinant chromosomes. 
Gap repair assay 
The P{wa} gap repair assay was performed as a slightly modified version of the one 
described by (Adams et al. 2003). In short, females containing the P{wa} element and 
heterozygous for the mus302D1 allele were crossed to males carrying P transposase and 
heterozygous for the mus3021882 allele. Single male progeny of this cross carrying the P{wa} 
construct and expressing the P transposase and either heterozygous for mus302Z1882 or 
heteroallelic for both mus302 mutations, were crossed to females with the compound X 
chromosome C(1)DX. Male progeny that did not inherit transposase were scored as “red-eyed” 
(SDSA), “white-eyed” (TMEJ), or “apricot-eyed” (mostly no excision but possibly full restoration 
of P{wa}). 
Amino acid sequence alignment 
The sequences for the RFWD3 orthologs in Homo sapiens, Mus musculus, Gallus 
gallus, Xenopus tropicalis, Danio rerio, Strongylocentrotus purpuratus, and Drosophila 
melanogaster were downloaded from Ensembl. Protein sequences were aligned in ClustalX 2.1 
(Larkin et al. 2007) and edited in GeneDoc 2.7.000 (Nicholas et al. 1997). 
Statistical analysis 
Statistical analyses were performed with Prism 8 (GraphPad). Tests are indicated in 
figure legends. Statistical significance is defined as p<0.05. 
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Data and reagent availability 
Drosophila stocks and plasmids are available upon request. 
Results and discussion 
mus302 encodes the Drosophila melanogaster ortholog of the human RFWD3 
We sought to map one of the uncharacterized mutagen-sensitive (mus) 
complementation groups in the third chromosome of Drosophila melanogaster, mus302, to a 
defined chromosomal location. mus302 alleles (D1 through D6) were first isolated by (Boyd et 
al. 1981) as conferring hypersensitivity to methyl methanesulfonate (MMS). (Laurencon et al. 
2004) found five additional mus302 mutations in another screen (Z1882, Z4933, Z6004, Z2530 
and Z5541). We confirmed that Boyd’s mus302 complementation group corresponded to 
Laurençon’s by testing the sensitivity to 0.025% MMS in mus302D1/mus302Z1882 heteroallelic 
mutants and observing that this dose is lethal to these mutants but not their heterozygous 
siblings (Fig. 1A).  
mus302 had been mapped previously between the phenotypic markers scarlet (st, 
recombination map 3-44) and curled (cu, recombination map 3-50) (Boyd et al. 1981). This 
region spans more than 5 Mb and hundreds of predicted genes, so we used recombination 
mapping to more finely localize mus302. Our data showed that mus302 is close to st. We next 
used deficiency mapping and found that mus302 is included in a set of 22 genes within the 
overlap between the deletions Df(3L)ED4606 and Df(3L)ED4674. Analyzing the current 
literature on the proteins encoded by the genes in this region suggested the predicted gene 
CG13025, which encodes the ortholog of the human RING Finger and WD domain protein 3 
(RFWD3), as our primary candidate to be mus302. Similar to human RFWD3, CG13025 has an 
N-terminal RING finger domain (containing the catalytic cysteine), a coiled coil structural motif, 
and a C-terminal WD domain (Fig. 1C).  
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Figure 6.1. Mus302 is an ortholog of RFWD3. A) Survival of flies exposed to 0.025% methyl 
methanesulfonate of the indicated genotype with respect to the untreated progeny from the 
same parents. Chromosomes with wild-type mus302 had the mus312Z1973 mutation (crossed 
to mus302D1) or the mus312D1 mutation (crossed to mus302Z1882). Each dot represents a vial, 
horizontal bar represents the mean and error bars the standard deviation. Horizontal dashed 
line at Y=1 indicates 100% survival. B) Schematic of the third chromosome of Drosophila 
melanogaster (circle represents the centromere, not to scale). Numbers represent the genetic 
position of st (44) and cu (50). After crossover mapping, we observed that mus302 was close 
to st. Deficiency mapping narrowed the region to 22 possible genes. The predicted gene 
CG13025 was our primary candidate. C) Schematic of Homo sapiens (Hsa) RFDW3 and 
Drosophila melanogaster (Dme) CG13025. RING finger and WD domain boundaries were 
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determined with the Conserved Domain tool from NCBI (Marchler-Bauer et al. 2013) and the 
coiled-coil motif with DeepCoil (Ludwiczak et al. 2019). The asterisk represents the catalytic 
cysteine required for ubiquitin ligase activity (based on mutants of the human protein). D) 
Schematic of the Drosophila melanogaster CG13025 including the amino acid changes found 
in the indicated mus302 alleles; the base substitutions that lead to the amino acid changes 
are: D2, A1T; Z4933, G466A; Z6004, C400T; Z1882, T576A; D1/D3, T908A. E) Survival of 
heteroallelic msu302 mutants with a transgene of CG13025 integrated into 3R (99F8) (two 
independent integrants are shown, A and B). Each dot represents a vial, horizontal bar 
represents the mean and error bars the standard deviation. Horizontal dashed line at Y=1 
indicates 100% survival. 
 
We sequenced the CG13025 coding region of the six mus302 alleles that were available 
(D1, D2, D3, Z1882, Z4933 and Z6004) and found non-synonymous mutations in all of them 
that are either nonsense (Z1882) or missense mutations (Fig. 1D). D1 and D3 had the same 
mutations, suggesting they originated from the same mutational event or that perhaps stocks 
were mixed up in the ~30 years since these mutations were first isolated. Most missense 
mutations change highly conserved amino acids and are likely to be detrimental to the protein 
stability or function (D1, D3, Z4933 and Z6004, Fig. 1E); the D2 mutation alters the AUG start 
codon. Based on the DNA changes and the finding that all mutants are extremely sensitive to a 
dose of 0.025% MMS (Fig. 1F), we conclude that all alleles we analyzed are amorphic or 
severely hypomorphic. 
If the mutant alleles of mus302 correspond to mutations in CG13025, introducing a wild-
type copy of CG13025 should rescue the sensitivity of mus302 mutants to MMS. We amplified 
the coding sequence of CG13025 plus one kb upstream and integrated it into the right arm of 
the third chromosome (99F8 site) of D. melanogaster. Two independent integrants were isolated 
and recombined onto a chromosome containing the mus302D1 mutation. Flies with this 
chromosome in trans to mus302Z1882 were resistant to 0.05% MMS (Fig. 1G).  
The findings that a wild-type copy of CG13025 rescues the MMS-sensitivity phenotype 
of mus302 mutants, and that we found detrimental mutations in all six alleles of mus302 
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sequence leads us to conclude that mus302 is CG13025 and encodes the Drosophila ortholog 
of RFWD3. 
mus302 is not required for homologous recombination 
Human RFWD3 participates in the repair of collapsed replication forks and DSBs 
through homologous recombination (HR) by ubiquitylating RPA and RAD51, both of which 
promote HR (Elia et al. 2015; Inano et al. 2017). We hypothesized that Mus302 would work in a 
similar manner, especially since other the same screen identified other HR genes, including 
mus301 (ortholog of HELQ) (McCaffrey et al. 2006), and mus309 (ortholog of BLM) (Kusano et 
al. 2001). We tested the sensitivity of mus302 mutants to a moderate dose of hydroxyurea (HU, 
100 mM), which stalls replication, or ionizing radiation (IR, 1000 rads), which generates DSBs. 
Surprisingly, we observed a ratio of survival in treated vs. untreated mus302 mutant flies of 1.3 
for HU and 0.86 for IR (Fig. 6.2A, B). In the IR treatment, survival of the heteroallelic mutant is 
significantly different from one of the heterozygous controls (mus302D1, p=0.0096) but not from 
the other (mus302Z1882, p=0.23). This is likely due to the mus302D1 control having higher survival 
than expected; thus, we conclude that mus302 mutants are not hypersensitive to this dose of 
IR. Because flies harboring mutations in spn-A (encodes the Drosophila ortholog of RAD51), 
which is required for HR, are sensitive to lower doses of both agents (Staeva-Vieira et al. 2003; 




Figure 6.2. Mus302 is not required for 
homologous recombination. A) and B) Survival 
after exposure to 100 mM hydroxyurea (HU) (A) 
or 1000 rads of ionizing radiation (IR) (B), 
calculated as in Figure 1A. Horizontal bar 
represents the mean and error bars the standard 
deviation. Statistical significance was determined 
by ANOVA with Bonferroni correction for multiple 
comparisons (NS, not significant; *p<0.05). 
Horizontal dashed line at Y=1 indicates 100% 
survival. C) Single males expressing a 
transposase, containing the P{wa} P element, 
mus302Z1882, and either mus302D1 or not (+) were 
crossed to fe-males with a compound X 
chromosome. Each dot represents the fraction of 
male progeny with either red eyes or white eyes, 
and not carrying the transposase, per vial. 
Horizontal bar represents the mean and error 
bars the standard deviation. Statistical 
significance was determined by two-tailed t-test 
(NS, not significant; *p<0.05). 
 
111 
In human cells lacking RFWD3, HR repair at either Ter-stalled replication forks or I-SceI-
generated DSBs is significantly decreased, as measured by a DR-GFP assay (Elia et al. 2015). 
We tested the ability of mus302 deficient flies to perform HR in another type of chromosomal 
break with a gap repair assay (P{wa}) (Adams et al. 2003). This assay takes advantage of a P 
element containing a hypomorphic version of the white gene that confers an orange eye color, 
inserted into the X chromosome. Excision of the P element creates a DSB that gives flies a red 
eye color if repaired by SDSA/HR, or a white eye color when repaired by Polymerase Theta-
Mediated End Joining (TMEJ). mus302 mutant flies exhibit no apparent defect in either repair 
pathway (Fig 6.2C). 
In contrast to cells deficient in RFWD3, mus302 mutants are not sensitive to HU or IR 
and are proficient in SDSA. We conclude that the functions described for human RFWD3 are 
not shared with the Drosophila ortholog. 
Mus302 functions independently of Spn-A 
Given that both mus302 and spn-A (the RAD51 ortholog) mutants are sensitive to MMS 
(albeit different MMS concentrations are required to see such sensitivity (Staeva-Vieira et al. 
2003)) and that RAD51 has functions outside of HR, it remains formally possible that they are 
part of the same pathway. Hence, we directly tested such possibility. 
We exposed mus302 and spn-A single and double mutants to increasing concentrations 
of MMS (0%, 0.001%, 0.025%). In untreated flies, we did not observe any differences in viability 
between the three genotypes (Fig. 6.3); however, at the low dose of 0.001% MMS, mus302 
spn-A double mutants had significantly reduced survival compared to mus302 single mutants 
(Fig. 3). As previously reported, a dose of 0.025% MMS is lethal for mus302 single mutants but 
not for spn-A mutants (Boyd et al. 1981; Staeva-Vieira et al. 2003); double mutants are also 
highly sensitive to this dose (Fig. 6.3). These results show that, unlike their human orthologs, 
Mus302 and Spn-A are part of different DNA repair pathways. 
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ATR phosphorylation motifs of RFWD3 appeared late in evolution 
To understand the functional differences observed between the human and the 
Drosophila orthologs, we performed a protein sequence alignment between different RFWD3 
orthologs. In addition to the human and the fly proteins, we used sequences from five other 
animal species: mouse (Mus musculus), chicken (Gallus gallus), frog (Xenopus tropicalis), 
zebrafish (Danio rerio) and sea urchin (Strongylocentrotus purpuratus). We observed a high 
conservation across species from the beginning of the RING finger through the end of the 
protein. However, the sequence upstream of the RING finger showed low conservation (Fig. 
6.4). 
 
Figure 6.3. Mus302 functions independently of Spn-A. 
Survival after exposure to the indicated dose of MMS was 
calculated as in Fig. 1A. Dots represent the mean and error bars 
the standard error of the mean (n ≥ 5 biological replicates, each 
vial represents a biological replicate). Statistical significance was 
determined by ANOVA with Bonferroni correction for multiple 
comparisons (NS, not significant; *p<0.05) for each 
concentration of MMS. An outlier was removed from the spn-A, 
0.001% MMS with ROUT test, Q = 1%. Horizontal dashed line at 
Y=1 indicates 100% survival. 
 
Since it is the C-terminus of the human RFWD3 that interacts with RPA32 (Liu et al. 
2011), we reasoned that this interaction may be conserved. Moreover, four amino acids in 
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RPA32 required for its interaction with RFWD3 are present in flies (Feeney et al. 2017). In 
contrast, the N-terminus of the human protein has two serines (S46 and S63) that are part of 
SQ motifs that are phosphorylated by ATR in response to DNA damage (Fu et al. 2010). They 
are also hypothesized to target RFWD3 repair to S phase. Strikingly, we observed that both 
serines are missing in the frog, zebrafish, and fly orthologs, and at least one is missing in the 
chicken and sea urchin proteins (there is a nearby SQ motif in these latter two species but the 
surrounding amino acids sequences are not conserved). 
 
Figure 6.4. The N terminus of RFWD3 appeared late in evolution. Protein alignment of 
seven RFWD3 orthologs performed as in Fig. 1F. Thin lines represent gaps introduced for 
optimal alignment. Black bars indicate conservation across all species examined; light colors 
represent conservation in a subset of species (see Fig. 1F). SQ indicates the two SQ motifs in 
human RFWD3 known to be phosphorylated by ATR. Domain boundaries shown for the 
human protein determined as in Fig. 1C. Asterisk indicates the catalytic cysteine. 
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Based on our analysis, we suggest that ATR phosphorylation of RFWD3 was acquired 
relatively recently on the mammalian phylogenetic branch. We speculate that Mus302 and other 
non-mammalian orthologs may be active outside of S phase, and that this may represent the 
ancestral function of the protein. This would explain our observation that Mus302 is not involved 
in homologous recombination, a DNA repair pathway most active during S phase in some 
organisms. 
Mus302 is required for survival in the presence of MMS. Alkylating damage is repaired 
outside of S phase by excision repair mechanisms (Kondo et al. 2010). Because most of the 
protein sequence of RFWD3 is conserved, it is possible that the human protein is also involved 
in the repair of alkylating damage outside of S phase, and that mus302 represents a 
“separation-of-function” ortholog that can be used to elucidate possible functions of RFWD3 in 
excision repair pathways. 
In summary, we have found that the mutagen sensitive complementation group mus302 
corresponds to the Drosophila melanogaster ortholog of the human RFWD3. The findings 
presented here show that Mus302 lacks the known functions of RFWD3 in promoting 
homologous recombination during replication fork collapse and DSB repair. Our analysis 
suggests that Mus302 may not be phosphorylated by the ATM/ATR kinases and we propose 
that this is responsible for the differences between the fly and the human protein. Further 
characterization of this gene in Drosophila has the potential to uncover new functions of the 
human protein. 
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